WO2015197393A1 - Pesticidal compositions - Google Patents

Pesticidal compositions Download PDF

Info

Publication number
WO2015197393A1
WO2015197393A1 PCT/EP2015/063269 EP2015063269W WO2015197393A1 WO 2015197393 A1 WO2015197393 A1 WO 2015197393A1 EP 2015063269 W EP2015063269 W EP 2015063269W WO 2015197393 A1 WO2015197393 A1 WO 2015197393A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
phenyl
chlorophenoxy
triazol
enantiomer
Prior art date
Application number
PCT/EP2015/063269
Other languages
French (fr)
Inventor
Frederik Menges
Martin Semar
Lutz Brahm
Annette SCHUSTER
Florent MAZUIR
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Priority to US15/319,963 priority Critical patent/US10212934B2/en
Priority to UAA201700550A priority patent/UA119672C2/en
Priority to CA2951177A priority patent/CA2951177C/en
Priority to EP17178393.9A priority patent/EP3269245B1/en
Priority to EA201790064A priority patent/EA032078B1/en
Priority to BR112016030116-1A priority patent/BR112016030116B1/en
Priority to EP15728026.4A priority patent/EP3160229A1/en
Priority to AU2015281187A priority patent/AU2015281187B2/en
Priority to CN201580033485.7A priority patent/CN106793776A/en
Publication of WO2015197393A1 publication Critical patent/WO2015197393A1/en
Priority to US16/245,469 priority patent/US20190142007A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/22—O-Aryl or S-Aryl esters thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/24—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing the groups, or; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof

Definitions

  • compositions comprising,
  • component I a compound selected from:
  • compound 1-1 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol; compound I-2 1 -[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1 - yl)ethanol;
  • compound I-8 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-cyclopropyl-2-methoxy-ethyl]- 1 ,2,4-triazole;
  • compound 1-1 1 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-cyclopropyl-2- methoxy-ethyl]-1 ,2,4-triazole;
  • compound 1-12 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-3,3-dimethyl-butyl]- 1 ,2,4-triazole;
  • compound 1-13 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy-butyl] 1 ,2,4- triazole;
  • compound 1-15 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy- pent-3-ynyl]-1 ,2,4-triazole;
  • compound 1-16 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)but-3- yn-2-ol; compound 1-17 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol; compound 1-18 2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol; compound 1-19 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 -yl)butan- 2-ol;
  • compound I-20 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-propyl]-1 ,2,4-triazole; compound 1-21 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-butyl]-1 ,2,4-riazole; compound I-22 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pentyl]-1 ,2,4-triazole; compound I-23 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 ,1 ,1 -trifluoro-3-(1 ,2,4-triazol-1 - yl)propan-2-ol;
  • compound I-25 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-4-yn-2-ol; compound I-26 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 - yl)propan-2-ol;
  • oxathiapiprolin 11-1
  • triadimenol II-2
  • sulfoxaflor II-3
  • methiocarb II-4
  • cypermethrin II-5
  • thiodicarb II-6
  • triflumezopyrim meoionic
  • flupyradifurone II-8
  • compositions comprising,
  • component I a compound selected from:
  • compound 1-1 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol; compound I-2 1 -[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1 - yl)ethanol;
  • compound I-3 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol; compound 1-4 1 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl-2-(1 ,2,4- triazol-1 -yl)ethanol;
  • the invention furthermore relates to the use of the inventive compositions as pesticides in particular for controlling phytopathogenic fungi as detailled herein and preparations or compositions comprising them.
  • the invention furthermore also relates to seed comprising the compositions.
  • the invention furthermore also relates to methods for controlling pests, in particular phytopathogenic fungi as detailled herein, wherein the fungi or the materials, plants, the soil or seed to be protected from fungal attack are treated with an effective amount of a compositions according to the invention.
  • the invention furthermore also relates to processes for preparing the compositions according to the invention.
  • compositions which, at a reduced total amount of active compounds applied, show improved activity against important pests, in particular phythopathogenic fungi, in particular for certain indications. It was a further object to provide for compositions that are useful for the control of specific pathogens in specific important crops that are often susceptible to the attack of pathogens.
  • the compounds I can be obtained by various routes in analogy to prior art processes known (cf. J.Agric. Food Chem. (2009) 57, 4854-4860; EP 0 275 955 A1 ; DE 40 03 180 A1 ; EP 0 1 13 640 A2; EP 0 126 430 A2). Furthermore, compounds I (component I), its preparation and use in crop protection are described in WO 2013/007767
  • the component I Owing to the basic character of their nitrogen atoms, the component I, i.e in particular compound 1-1 , I-2, I-3, I-4, I-5, I-6, I-7, I-8, I-9, 1-10, 1-1 1 , 1-12, 1-13, 1-14, 1-15, 1-16, 1-17, 1-18, 1-19, I-20, 1-21 , I-22, I-23, I-24, I-25, I-26, I-27, I-28, I-29, I-30 and 1-31 or any group of compounds I detailled above, is capable of forming salts or adducts with inorganic or organic acids or with metal ions, in particular salts with inorganic acids.
  • I-4 1 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1 ⁇
  • I-6 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pent-3-ynyl]-1 ,2,4-triazole
  • I-8 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-cyclopropyl-2-methoxy-ethyl]-1 ,2,4-triazole
  • inorganic acids examples include hydrohalic acids, such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, carbonic acid, sulfuric acid, phosphoric acid and nitric acid.
  • Suitable organic acids are, for example, formic acid and alkanoic acids, such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, and also glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid and other arylcarboxylic acids, cinnamic acid, oxalic acid, alkylsulfonic acids (sulfonic acids having straight-chain or branched alkyl radicals of 1 to 20 carbon atoms), arylsulfonic acids or aryldisulfonic acids (aromatic radicals, such as phenyl and naphthyl, which carry one or two sulfonic acid groups), alkylphosphonic acids (phosphonic acids having straight-chain or branched alkyl radicals with 1 to 20 carbon atoms), arylphosphonic acids or aryldiphosphonic acids
  • Suitable metal ions are in particular the ions of the elements of the second main group, in particular calcium and magnesium, of the third and fourth main group, in particular aluminum, tin and lead, and also of the elements of transition groups one to eight, in particular chromium, manganese, iron, cobalt, nickel, copper, zinc, and others. Particular preference is given to the metal ions of the elements of transition groups of the fourth period.
  • the metals can be present in the various valencies that they can assume.
  • Components I comprise chiral centers and they are generally obtained in the form of racemates.
  • the R- and S-enantiomers of the compounds according to the invention can be separated and isolated in pure form with methods known by the skilled person, e.g. by using chiral HPLC.
  • Suitable for use as antimicrobial agents are both the enantiomers and compositions thereof. This applies correspondingly to the compositions.
  • components I can be present in different crystal modifications, which may differ in biological activity.
  • a racemic composition is present.
  • any other proportions of the (R)-enantiomer and the (S)-enantiomer may be present according to the present invention. This applies to every composition detained herein.
  • component I is compound 1-1.
  • Compound 1-1 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-1 .
  • the compound 1-1 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-1 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • Compound (R)-l-1 (R) -2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3- yn-2-ol;
  • Compound (S)-l-1 (S) -2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pent-3-yn-2-ol.
  • component I is compound I-2.
  • Compound I-2 may be present as racemic composition of the (R)-enantiomer and (S)-enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-2.
  • the compound I-2 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-2 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I- 3.
  • Compound I-3 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-3.
  • the compound I-3 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-3 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • Compound (R)-l-3 (R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol; compound (S)-l-3: (S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 - (1 ,2,4-triazol-1 -yl)propan-2-ol.
  • component I is compound I-
  • Compound I-4 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-4.
  • the compound I-4 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-4 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-5 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-5.
  • the compound I-5 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-5 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-6 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-6.
  • the compound I-6 is provided and used as (R)- enantiomer with an enantomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • the compound I-6 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • component I is compound I-
  • Compound I-7 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-7.
  • the compound I-7 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-7 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • compound (S)-l-7 (S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol; compound (R)-l-7: (R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 - (1 ,2,4-triazol-1 -yl)butan-2-ol.
  • component I is compound I-
  • Compound I-8 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-8.
  • the compound I-8 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-8 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-9 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-9.
  • the compound I-9 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-9 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I- 10.
  • Compound 1-10 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-10.
  • the compound 1-10 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-10 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I- 1 1 .
  • Compound 1-1 1 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-1 1 .
  • the compound 1-1 1 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-1 1 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound 1-12 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-12.
  • the compound 1-12 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-12 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound 1-13 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-13.
  • the compound 1-13 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-13 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound 1-14 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-14.
  • the compound 1-14 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • the compound 1-14 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound 1-15 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-15.
  • the compound 1-15 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-15 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound 1-16 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-16.
  • the compound 1-16 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-16 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound 1-17.
  • Compound 1-17 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-17.
  • the compound 1-17 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-17 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound 1-18.
  • Compound 1-18 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-18.
  • the compound 1-18 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-18 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I- 19.
  • Compound 1-19 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-19.
  • the compound 1-19 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-19 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-20 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-20.
  • the compound I-20 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-20 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound 1-21 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-21.
  • the compound 1-21 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-21 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • Compound (S)-l-21 (S)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-butyl]-1 ,2,4- triazole;
  • Compound (R)-l-21 (R)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-butyl]- 1 ,2,4-triazole.
  • component I is compound I-
  • Compound I-22 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-22.
  • the compound I-22 is provided and used as (R)- enantiomer with an enantomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantomeric excess e.e.
  • the compound I-22 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-23 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-23.
  • the compound I-23 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-23 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-24 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-24.
  • the compound I-24 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • the compound I-24 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • component I is compound I-
  • Compound I-25 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-25.
  • the compound I-25 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-25 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-26 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-26.
  • the compound I-26 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-26 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-27 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-27.
  • the compound I-27 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-27 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I- 28.
  • Compound I-28 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-28.
  • the compound I-28 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-28 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I- 29.
  • Compound I-29 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-29.
  • the compound I-29 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-29 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound I-30 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-30.
  • the compound I-30 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound I-30 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is compound I-
  • Compound 1-31 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-31.
  • the compound 1-31 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • the compound 1-31 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
  • an enantiomeric excess e.e.
  • component I is selected from compounds 1-1 , I-2, I-3, I-4, I-5, I-6, I-7, I-8, I-9, 1-1 1 , 1-13, 1-14, 1-15 and 1-16. According to a more particular embodiment of the present invention, component I is selected from compounds 1-1 , I-2, I-6 and I-8. According to another more particular embodiment of the present invention, component I is selected from compounds I-3, I-4, I-5, I-7, I-9, 1-1 1 , 1-13, I- 14, 1-15 and 1-16.
  • component I is selected from compounds 1-1 , I-2, I-3, I-4 and I-5, more specifically selected from 1-1 , I-3, I-4 and I-5.
  • component I is selected from compounds I-3, I-4 and I-5.
  • oxathiapiprolin (11-1 ): 1 -(4- ⁇ 4-[(5RS)-5-(2,6-difluorophenyl)-4,5-dihydro-1 ,2-oxazol-3-yl]-1 ,3- thiazol-2-yl ⁇ -1 -piperidyl)-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1 -yl]ethanone
  • cypermethrin (II-5) (RS)-a-cyano-3-phenoxybenzyl (1 RS,3RS;1 RS,3SR)-3- ⁇ 2,2- dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate or (RS)-ocyano-3-phenoxybenzyl (1 RS)- c/s-frans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
  • flupyradifurone (II-8) 4-[(6-chloro-3-pyridylmethyl)(2,2-difluoroethyl)amino]furan-2(5/-/)-one
  • component II is selected the group of oxathiapiprolin (11-1 );
  • component II is selected from the group of oxathiapiprolin (11-1 );
  • compositions and their preferred uses are further described.
  • the use of the composition for controlling a particular pest, in particular phytopathogenic fungus is also meant to encompass the respective method for controlling the particular pest, in particular phytopathogenic fungi, wherein the fungi or the materials, plants, the soil or seed to be protected from attack are treated with an effective amount of a composition as defined herein.
  • compositions comprising two active compounds as defined are present in the inventive compositions (herein also called “binary compositions").
  • the composition may, of course, contain any kind of additive or the like as detained below in order to provide a formulation suitable for use in agriculture.
  • the weight ratio of component I to component II depends from the properties of the active substances used and is usually in the range of from 1:1000 to 1000:1, more particularly 1 :500 to 500:1.
  • the weight ratio of component I to component II may preferably be in the range of from 1:100 to 100:1, frequently in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, particularly preferably in the range of from 1:10 to 10:1, in particular in the range of from 1:3 to 3:1. It may also be preferable for the weight ratio to be in the range of from 1 :2 to 2:1.
  • the weight ratio of component I to component II usually is in the range of from 1:1 to 1:100, regularly in the range of from 1:1 to 1:50, preferably in the range of from 1:1 to 1:20, more preferably in the range of from 1:1 to 1:10, even more preferably in the range of from 1:1 to 1:4 and in particular in the range of from 1:1 to 1:2.
  • two-component compositions according to the invention may preferably have weight ratios of compound I versus compound II in the range of from 1000:1 to 1:1, often in the range of from 100:1 to 1:1, regularly in the range of from 50:1 to 1:1, preferably in the range of from 20:1 to 1:1, more preferably in the range of from 10:1 to 1:1, even more preferably in the range of from 4:1 to 1:1 and in particular in the range of from 2:1 to 1:1.
  • compositions of the invention are compiled in Table B1, wherein each row corresponds to one embodiment of the compositions according to the invention, i.e. one specific individualized composition. According to one specific aspect, these are binary compositions which each only contain these two components as active compounds.
  • compositions individualized in this table represent embodiments of the present invention.
  • Table B1 Two-component compositions B1-1 to B1-248 comprising one component I and a component II, in particular binary compositions containing the respective component I and II as only active ingredients:
  • the weight ratio of component I to component II in the compositions B1-1 to B1-248 depends from the properties of the active substances used and is usually in the range of from 1 :1000 to 1000:1 , more particularly 1 :500 to 500:1 .
  • the weight ratio of component I to component II in the compositions B1 -1 to B1 -248 may preferably be in the range of from 1 :100 to 100:1 , frequently in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , particularly preferably in the range of from 1 :10 to 10:1 , in particular in the range of from 1 :3 to 3:1 . It may also be preferable for the weight ratio to be in the range of from 1 :2 to 2:1 .
  • the weight ratio of component I to component II usually is in the range of from 1 :1 to 1 :100, regularly in the range of from 1 :1 to 1 :50, preferably in the range of from 1 :1 to 1 :20, more preferably in the range of from 1 :1 to 1 :10, even more preferably in the range of from 1 :1 to 1 :4 and in particular in the range of from 1 :1 to 1 :2.
  • compositions B1 -1 to B1 -248 according to the invention may preferably have weight ratios of component I versus compound II in the range of from 1000:1 to 1 :1 , often in the range of from 100:1 to 1 :1 , regularly in the range of from 50:1 to 1 :1 , preferably in the range of from 20:1 to 1 :1 , more preferably in the range of from 10:1 to 1 :1 , even more preferably in the range of from 4:1 to 1 :1 and in particular in the range of from 2:1 to 1 :1.
  • One embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1000:1 to 1 :1000.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 500:1 to 1 :500.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 100:1 to 1 :100.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :100 to 100:1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :50 to 50:1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :20 to 20:1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :10 to 10:1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :3 to 3:1.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :2 to 2:1.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1000:1 to 1 :1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 100:1 to 1 :1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 50:1 to 1 :1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 20:1 to 1 :1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 10:1 to 1 :1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 4:1 to 1 :1 .
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 2:1 to 1 :1.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1000.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :100.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :50.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :20.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :10.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :4.
  • One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :2.
  • the components I contain chirality centers and may, therefore, be present as racemic mixtures, as pure enantiomers or in the two enantiomers of one component I may be present in any ratio (S):(R).
  • the respective component I is present as (S) enantiomer. According to particular embodiments of the invention, the respective component I is present as (R) enantiomer. According to one specific aspect, these are binary compositions which each only contain these two components as active compounds.
  • compositions according to the invention are suitable as fungicides. They are
  • Plasmodiophoromycetes Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti).
  • Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.
  • compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e. g. apples, pears, plums, peaches, almonds, cherries,
  • strawberries, raspberries, blackberries or gooseberries leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rape, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens
  • inventive compositions are used for controlling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
  • field crops such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
  • plant propagation material is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.
  • treatment of plant propagation materials with the inventive combination of pesticides I and pesticides II and compositions thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.
  • cultiva plants is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://cera-gmc.org/, see GM crop database therein).
  • Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination.
  • one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant.
  • Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g.
  • hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors HPPD
  • acetolactate synthase (ALS) inhibitors such as sulfonyl ureas (see e. g. US 6,222,100, WO 01/82685, WO 00/26390, WO 97/41218, WO 98/02526, WO 98/02527, WO 04/106529, WO 05/20673, WO 03/14357, WO 03/13225, WO 03/14356, WO 04/16073) or imidazolinones (see e. g. US 6,222,100, WO 01/82685, WO 00/026390, WO 97/41218, WO 98/002526, WO 98/02527,
  • EPSPS enolpyruvylshikimate-3-phosphate synthase
  • GS glutamine synthetase
  • glufosinate see e. g. EP-A 242 236, EP-A 242 246) or oxynil herbicides (see e. g.
  • cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), e. g. Clearfield ® summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox.
  • Genetic engineering methods have been used to render cultivated plants such as soybean, cotton, corn, beets and rape, tolerant to herbicides such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady ® (glyphosate-tolerant, Monsanto, U.S.A.) and LibertyLink ® (glufosinate-tolerant, Bayer CropScience, Germany).
  • plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus Bacillus, particularly from Bacillus thuringiensis, such as ⁇ -endotoxins, e. g. CrylA(b), CrylA(c), CrylF, CrylF(a2), CryllA(b), CrylllA, CrylllB(bl ) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1 , VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp.
  • VIP1 , VIP2, VIP3 or VIP3A vegetative insecticidal proteins
  • toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins
  • toxins produced by fungi such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins
  • proteinase inhibitors such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors
  • ribosome-inactivating proteins (RIP) such as ricin, maize-RIP, abrin, luffin, saporin or bryodin
  • steroid metabolism enzymes such as 3- hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase
  • ion channel blockers such as blockers of sodium or calcium
  • insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins.
  • Hybrid proteins are characterized by a new combination of protein domains, (see, e. g.
  • WO 95/34656 EP-A 427 529, EP-A 451 878, WO 03/18810 und WO 03/52073.
  • the methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.
  • These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of arthropods, especially to beetles (Coeloptera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda).
  • Genetically modified plants capable to synthesize one or more insecticidal proteins are, e.
  • Starlink ® corn cultivars producing the Cry9c toxin
  • Herculex ® RW corn cultivars producing Cry34Ab1 , Cry35Ab1 and the enzyme Phosphinothricin-A/-Acetyltransferase [PAT]
  • NuCOTN ® 33B cotton cultivars producing the CrylAc toxin
  • Bollgard ® I cotton cultivars producing the CrylAc toxin
  • Bollgard ® II cotton cultivars producing CrylAc and Cry2Ab2 toxins
  • VIPCOT ® cotton cultivars producing a VIP-toxin
  • NewLeaf ® potato cultivars producing the Cry3A toxin
  • Bt-Xtra ® NatureGard ® , KnockOut ® , BiteGard ® , Protecta ® , Bt1 1 (e. g.
  • plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens.
  • proteins are the so-called "pathogenesis-related proteins" (PR proteins, see, e. g. EP-A 392 225), plant disease resistance genes (e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora).
  • PR proteins pathogenesis-related proteins
  • plant disease resistance genes e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the mexican wild potato Solanum bulbocastanum
  • T4-lysozym e. g. potato cultiv
  • plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environmental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.
  • productivity e. g. bio mass production, grain yield, starch content, oil content or protein content
  • plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, e. g. oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera ® rape, DOW Agro Sciences, Canada).
  • plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora ® potato, BASF SE, Germany).
  • inventive compositions are particularly suitable for controlling the following plant diseases:
  • Albugo spp. white rust
  • vegetables e. g. A. Candida
  • sunflowers e. g. A. tragopogonis
  • Altemaria spp. Alternaria leaf spot) on vegetables, rape (A. brassicola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A.
  • alternata tomato (e. g. A. solani or A. alternata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e. g. A. tritici
  • Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spots) on corn, rice, sugar beets (e. g. C. beticola), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. kikuchii) and rice; Cladosporium spp. on tomatoes (e. g. C. fulvum: leaf mold) and cereals, e. g. C.
  • herbarum black ear
  • Claviceps purpurea ergot
  • Cochliobolus anamorph: Helminthosporium of Bipolaris
  • spp. leaf spots
  • corn C. carbonum
  • cereals e. g. C. sativus, anamorph: B. sorokiniana
  • rice e. g. C. miyabeanus, anamorph: H. oryzae
  • Colletotrichum teleomorph: Glomerella
  • spp. anthracnose
  • Cylindrocarpon spp. e. g. fruit tree canker or young vine decline, teleomorph: Nectria or Neonectria spp.
  • vines e. g. C. liriodendri, teleomorph: Neonectria liriodendri: Black Foot Disease
  • Dematophora teleomorph: Rosellinia
  • necatrix root and stem rot
  • Diaporthe spp. e. g. D. phaseolorum (damping off) on soybeans
  • Drechslera syn. Helminthosporium, teleomorph: Pyrenophora
  • cereals such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formitiporia (syn. Phellinus) punctata, F.
  • Phaeomoniella chlamydospora (earlier Phaeoacremonium chlamydosporum), Phaeoacremonium aleophilum and/or Botryosphaeria obtusa
  • Elsinoe spp. on pome fruits £. pyri
  • soft fruits £. veneta: anthracnose
  • vines £. ampelina: anthracnose
  • Entyloma oryzae leaf smut
  • Epicoccum spp. black mold
  • Erysiphe spp. (powdery mildew) on sugar beets (£. betae)
  • vegetables e. g. E. pisi), such as cucurbits (e. g. E. E.
  • Bakanae disease Glomerella cingulata on vines, pome fruits and other plants and G.
  • Cladosporium vitis on vines; Macrophomina phaseolina (syn. phaseoli) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink snow mold) on cereals (e. g. wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., e. g. M. laxa, M. fructicola and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, bananas, soft fruits and ground nuts, such as e. g. M.
  • graminicola anamorph: Septoria tritici, Septoria blotch
  • M. fijiensis black Sigatoka disease
  • Peronospora spp. downy mildew
  • cabbage e. g. P. brassicae
  • rape e. g. P. parasitica
  • onions e. g. P. destructor
  • tobacco P.
  • soybeans e. g. P. manshurica
  • Phakopsora pachyrhizi and P. meibomiae soybean rust
  • Phialophora spp. e. g. on vines e. g. P. tracheiphila and P. tetraspora
  • soybeans e. g. P. gregata: stem rot
  • Phoma lingam root and stem rot
  • rape and cabbage P. betae (root rot, leaf spot and damping-off) on sugar beets
  • P. betae root rot, leaf spot and damping-off
  • Plasmodiophora brassicae club root
  • Plasmopara spp. e. g. P. viticola (grapevine downy mildew) on vines and P. halstedii on sunflowers
  • Podosphaera spp. powdery mildew on rosaceous plants, hop, pome and soft fruits, e. g. P. leucotricha on apples
  • Polymyxa spp. e. g. on cereals, such as barley and wheat (P. graminis) and sugar beets (P.
  • Pseudocercosporella herpotrichoides eyespot, teleomorph: Tapesia yallundae
  • Pseudoperonospora downy mildew
  • Pseudopezicula tracheiphila red fire disease or .rotbrenner', anamorph: Phialophora
  • Puccinia spp. rusts on various plants, e. g. P. triticina (brown or leaf rust), P.
  • striiformis stripe or yellow rust
  • P. hordei dwarf rust
  • P. graminis seed or black rust
  • P. recondita brown or leaf rust
  • cereals such as e. g. wheat, barley or rye, and asparagus (e. g. P. asparagi); Pyrenophora (anamorph: Drechslera) tritici-repentis (tan spot) on wheat or P. feres (net blotch) on barley; Pyricularia spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P.
  • grisea on turf and cereals Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Ramularia spp., e. g. R. collo-cygni (Ram ularia leaf spots,
  • Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stolonifer (black mold, soft rot) on strawberries, carrots, cabbage, vines and tomatoes; Rhynchosporium secalis (scald) on barley, rye and triticale; Sarocladium oryzae and S. attenuatum (sheath rot) on rice;
  • Sclerotinia spp. stem rot or white mold
  • vegetables and field crops such as rape, sunflowers (e. g. S. sclerotiorum) and soybeans (e. g. S. rolfsii or S. sclerotiorum); Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici (Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Uncinula (syn.
  • Erysiphe necator prowdery mildew, anamorph: Oidium tuckeri
  • Setospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Helminthosporium turcicum) and turf;
  • Sphacelotheca spp. (smut) on corn, (e. g. S. miliaria: head smut), sorghum und sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora spp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph: Leptosphaeria [syn.
  • occulta stem smut
  • Uromyces spp. rust
  • vegetables such as beans (e. g. U. appendiculatus, syn. U. phaseoli) and sugar beets (e. g. U. betae)
  • Ustilago spp. loose smut) on cereals (e. g. U. nuda and U. avaenae), corn (e. g. U. maydis: corn smut) and sugar cane
  • Venturia spp. scab
  • apples e. g. V. inaequalis
  • pears Verticillium spp.
  • compositions of the present invention are effective against plant pathogens in speciality crops such as vine, fruits, hop, vegetables and tabacco - see above list.
  • the inventive compositions are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials.
  • the term "protection of materials” is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, colling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria.
  • Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp.,
  • the method of treatment according to the invention can also be used in the field of protecting stored products or harvest against attack of fungi and microorganisms.
  • the term "stored products” is understood to denote natural substances of plant or animal origin and their processed forms, which have been taken from the natural life cycle and for which long-term protection is desired.
  • Stored products of crop plant origin such as plants or parts thereof, for example stalks, leafs, tubers, seeds, fruits or grains, can be protected in the freshly harvested state or in processed form, such as pre-dried, moistened, comminuted, ground, pressed or roasted, which process is also known as post-harvest treatment.
  • Also falling under the definition of stored products is timber, whether in the form of crude timber, such as construction timber, electricity pylons and barriers, or in the form of finished articles, such as furniture or objects made from wood.
  • Stored products of animal origin are hides, leather, furs, hairs and the like.
  • the combinations according the present invention can prevent disadvantageous effects such as decay, discoloration or mold.
  • stored products is understood to denote natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pomes, stone fruits, soft fruits and citrus fruits and their processed forms.
  • Plant propagation materials may be treated with the compositions of the invention prophylactically either at or before planting or transplanting.
  • the invention also relates to agrochemical compositions comprising an auxiliary and at least one compound I and at least one pesticide II according to the invention.
  • An agrochemical composition comprises a fungicidally effective amount of a compound I and a pesticide II.
  • effective amount denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound I used.
  • compositions e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof.
  • composition types are suspensions (e. g. SC, OD, FS), emulsifiable concentrates (e. g. EC), emulsions (e. g. EW, EO, ES, ME), capsules (e. g. CS, ZC), pastes, pastilles, wettable pow- ders or dusts (e. g.
  • compositions are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.
  • Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.
  • Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e. g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin,
  • Suitable solid carriers or fillers are mineral earths, e. g.
  • silicates silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e. g. cellulose, starch; fertilizers, e. g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e. g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.
  • Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1 : Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).
  • Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof.
  • sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignin sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and
  • tridecylbenzenes sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates.
  • sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters.
  • phosphates are phosphate esters.
  • carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.
  • Suitable nonionic surfactants are alkoxylates, N-subsituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof.
  • alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents.
  • Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide.
  • N-subsititued fatty acid amides are fatty acid glucamides or fatty acid alkanolamides.
  • esters are fatty acid esters, glycerol esters or monoglycerides.
  • sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides.
  • polymeric surfactants are home- or copolymers of vinylpyrrolidone, vinylalcohols, or vinylacetate.
  • Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines.
  • Suitable amphoteric surfactants are alkylbetains and imidazolines.
  • Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide.
  • Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinyl amines or polyethylene amines.
  • Suitable adjuvants are compounds, which have a negligible or even no pesticidal activity themselves, and which improve the biological performance of the compound I on the target.
  • examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.
  • Suitable thickeners are polysaccharides (e. g. xanthan gum, carboxymethyl cellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.
  • Suitable bactericides are bronopol and isothiazolinone derivatives such as alkyliso- thiazolinones and benzisothiazolinones.
  • Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.
  • Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.
  • Suitable colorants are pigments of low water solubility and water- soluble dyes.
  • examples are inorganic colorants (e. g. iron oxide, titan oxide, iron
  • organic colorants e. g. alizarin-, azo- and phthalocyanine colorants.
  • Suitable tackifiers or binders are polyvinyl pyrrolidones, polyvinyl acetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.
  • composition types and their preparation are (wherein active substances denote at least one compound I and one compound II):
  • active substances 10-60 wt% active substances and 5-15 wt% wetting agent (e. g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e. g. alcohols) ad 100 wt%.
  • wetting agent e. g. alcohol alkoxylates
  • a water-soluble solvent e. g. alcohols
  • dispersant e. g. polyvinyl pyrrolidone
  • organic solvent e. g. cyclohexanone
  • Emulsifiable concentrates 15-70 wt% active substances and 5-10 wt% emulsifiers (e. g. calcium dodecylben- zenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%. Dilution with water gives an emulsion.
  • emulsifiers e. g. calcium dodecylben- zenesulfonate and castor oil ethoxylate
  • Emulsions (EW, EO, ES)
  • emulsifiers e. g. calcium dodecylben- zenesulfonate and castor oil ethoxylate
  • 20-40 wt% water-insoluble organic solvent e. g. aromatic hydrocarbon
  • This mixture is introduced into water ad 100 wt% by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion.
  • active substances are comminuted with addition of 2-10 wt% dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate), 0.1 -2 wt% thickener (e. g. xanthan gum) and ad water ad 100 wt% to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance.
  • dispersants and wetting agents e. g. sodium lignosulfonate and alcohol ethoxylate
  • 0.1 -2 wt% thickener e. g. xanthan gum
  • ad water ad 100 wt%
  • active substances are ground finely with addition of dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt% and prepared as water-dispersible or water-soluble granules by means of technical appliances (e. g.
  • active substances are ground in a rotor-stator mill with addition of 1 -5 wt% dispersants (e. g. sodium lignosulfonate), 1 -3 wt% wetting agents (e. g. alcohol ethoxylate) and solid carrier (e. g. silica gel) ad 100 wt%. Dilution with water gives a stable dispersion or solution of the active substance.
  • dispersants e. g. sodium lignosulfonate
  • wetting agents e. g. alcohol ethoxylate
  • solid carrier e. g. silica gel
  • active substances are comminuted with addition of 3-10 wt% dispersants (e. g. sodium lignosulfonate), 1 -5 wt% thickener (e. g. carboxymethyl cellulose) and water ad 100 wt% to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.
  • dispersants e. g. sodium lignosulfonate
  • 1 -5 wt% thickener e. g. carboxymethyl cellulose
  • 5-20 wt% active substances are added to 5-30 wt% organic solvent blend (e. g. fatty acid dimethylamide and cyclohexanone), 10-25 wt% surfactant blend (e. g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100 wt%. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.
  • organic solvent blend e. g. fatty acid dimethylamide and cyclohexanone
  • surfactant blend e. g. alcohol ethoxylate and arylphenol ethoxylate
  • An oil phase comprising 5-50 wt% active substances, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e. g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules.
  • an oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), and an isocyanate monomer (e. g.
  • diphenylmethene-4,4'-diisocyanatae are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol).
  • a protective colloid e. g. polyvinyl alcohol.
  • the addition of a polyamine results in the formation of polyurea microcapsules.
  • the monomers amount to 1 -10 wt%.
  • the wt% relate to the total CS composition.
  • Dustable powders (DP, DS)
  • active substances are ground finely and mixed intimately with solid carrier (e. g. finely divided kaolin) ad 100 wt%.
  • solid carrier e. g. finely divided kaolin
  • active substances are ground finely and associated with solid carrier (e. g.
  • organic solvent e. g. aromatic hydrocarbon
  • compositions types i) to xi) may optionally comprise further auxiliaries, such as 0.1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.
  • auxiliaries such as 0.1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.
  • the agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of active
  • the active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).
  • compositions in question give, after two-to-tenfold dilution, active substance
  • Application can be carried out before or during sowing.
  • Methods for applying or treating compound I and compound II and compositions thereof, respectively, onto plant propagation material, especially seeds include dressing, coating, pelleting, dusting, and soaking as well as in-furrow application methods.
  • compound I and pesticide II or the compositions thereof, respectively are applied on to the plant propagation material by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating and dusting.
  • the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, in particular from 0.1 to 0.75 kg per ha.
  • amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seed) are generally required.
  • the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.
  • oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides may be added to the active substances or the compositions comprising them as premix or, if appropriate not until immediately prior to use (tank mix).
  • pesticides e. g. herbicides, insecticides, fungicides, growth regulators, safeners
  • These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.
  • the user applies the composition according to the invention usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system.
  • the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained.
  • 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.
  • the compound ratios are advantageously chosen so as to produce a synergistic effect.
  • the active compounds are prepared as a stock solution comprising 25 mg of active compound which is made up to 10 ml using a mixture of acetone and/or DMSO and the emulsifier Uniperol ® EL (wetting agent having an emulsifying and dispersing action based on ethoxylated alkylphenols) in a ratio by volume of solvent/emulsifier of 99:1.
  • the mixture is then made up to 100 ml with water.
  • This stock solution is diluted with the solvent/emulsifier/water mixture described to give the concentration of active compound stated below.
  • the visually determined percentages of infected leaf areas are converted into efficacies in % of the untreated control.
  • the efficacy (E) is calculated as follows using Abbot's formula
  • ⁇ corresponds to the fungicidal infection of the untreated (control) plants in %
  • An efficacy of 0 means that the infection level of the treated plants corresponds to that of the untreated control plants; an efficacy of 100 means that the treated plants were not infected.
  • the expected efficacies of active compound combinations were determined using Colby's formula (Colby, S.R. "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds, 1J5, pp. 20-22, 1967) and compared with the observed efficacies.
  • y efficacy expressed in % of the untreated control, when using the active compound B at the concentration b.
  • compositions according to the invention can be shown by the tests described below.
  • the active compounds were formulated separately as a stock solution having a concentration of 10000 ppm in dimethyl sulfoxide.
  • the product sulfoxaflor was used as a commercial finished formulation and diluted with water to the stated concentration of the active compound.
  • the stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations.
  • MTP micro titer plate
  • a spore suspension of Phytophtora infestans containing a pea juice-based aqueous nutrient medium or DDC medium was then added.
  • the plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
  • the stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations.
  • MTP micro titer plate
  • a spore suspension of Botrci cinerea in an aqueous biomalt or yeast-bactopeptone-sodiumacetate solution was then added.
  • the plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
  • the stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations.
  • MTP micro titer plate
  • a spore suspension of Pyricularia oryzae in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added.
  • the plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
  • the stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations.
  • MTP micro titer plate
  • a spore suspension of Septoria tritici in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added.
  • the plates were placed in a water vapor-saturated chamber at a temperature of 18°C.
  • the MTPs were measured at 405 nm 7 days after the inoculation.
  • the stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations.
  • MTP micro titer plate
  • a spore suspension of Alternaria solani in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added.
  • the plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
  • the stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations.
  • MTP micro titer plate
  • a spore suspension of Leptosphaeria nodorum in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added.
  • the plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
  • the measured parameters were compared to the growth of the active compound-free control variant (100%) and the fungus-free and active compound-free blank value to determine the relative growth in % of the pathogens in the respective active compounds.
  • An efficacy of 0 means that the growth level of the pathogens corresponds to that of the untreated control; an efficacy of 100 means that the pathogens were not growing.

Abstract

The present invention relates to compositions comprising a specified triazole compound (I-1 to I-31) as component I and one of oxathiapiprolin, triadimenol, sulfoxaflor, methiocarb, cypermethrin, thiodicarb, triflumezopyrim (Mesoionic), flupyradifurone as component II. It also relates to the use of the compositions for combating phytopathogenic fungi, to a method for combating phytopathogenic fungi as well as to plant propagation material coated with the compositions.

Description

Pesticidal compositions
Description
The present invention relates to compositions comprising,
1 ) as component I a compound selected from:
compound 1-1 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol; compound I-2 1 -[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1 - yl)ethanol;
compound I-3 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol;
compound I-4 1 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl-2-(1 ,2,4- triazol-1 -yl)ethanol;
compound I-5 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1 -(1 ,2,4-triazol-
1 - yl)butan-2-ol;
compound I-6 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pent-3-ynyl]-1 ,2,4- triazole;
compound I-7 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)butan-
2- ol;
compound I-8 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-cyclopropyl-2-methoxy-ethyl]- 1 ,2,4-triazole;
compound I-9 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy-propyl]- 1 ,2,4-triazole;
compound 1-10 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3,3-dimethyl-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol,
compound 1-1 1 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-cyclopropyl-2- methoxy-ethyl]-1 ,2,4-triazole;
compound 1-12 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-3,3-dimethyl-butyl]- 1 ,2,4-triazole;
compound 1-13 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy-butyl] 1 ,2,4- triazole;
compound 1-14 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-
3- yn-2-ol;
compound 1-15 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy- pent-3-ynyl]-1 ,2,4-triazole;
compound 1-16 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)but-3- yn-2-ol; compound 1-17 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol; compound 1-18 2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol; compound 1-19 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 -yl)butan- 2-ol;
compound I-20 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-propyl]-1 ,2,4-triazole; compound 1-21 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-butyl]-1 ,2,4-riazole; compound I-22 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pentyl]-1 ,2,4-triazole; compound I-23 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 ,1 ,1 -trifluoro-3-(1 ,2,4-triazol-1 - yl)propan-2-ol;
compound I-24 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-fluoro-1 -(1 ,2,4-triazol-1 -yl)butan- 2-ol hydrochloride;
compound I-25 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-4-yn-2-ol; compound I-26 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 - yl)propan-2-ol;
compound I-27 2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 - yl)propan-2-ol;
compound I-28 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pentan-2-ol;
compound I-29 and2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol;
compound I-30 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol; and compound 1-31 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pentan-2-ol; and
2) as component II a compound selected from the group of
oxathiapiprolin (11-1 ); triadimenol (II-2); sulfoxaflor (II-3); methiocarb (II-4); cypermethrin (II-5); thiodicarb (II-6); triflumezopyrim (mesoionic) (II-7) and flupyradifurone (II-8).
In particular, the present invention relates to compositions comprising,
1 ) as component I a compound selected from:
compound 1-1 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol; compound I-2 1 -[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1 - yl)ethanol;
compound I-3 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol; compound 1-4 1 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl-2-(1 ,2,4- triazol-1 -yl)ethanol;
compound I-5 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1 -(1 ,2,4-triazol- 1 -yl)butan-2-ol;
and
2) as component II a compound selected from the group of
oxathiapiprolin (11-1 ); triadimenol (II-2); sulfoxaflor (I I-3); methiocarb (II-4); cypermethrin (II-5); thiodicarb (II-6); triflumezopyrim (mesoionic) (II-7) and flupyradifurone (II-8).
The invention furthermore relates to the use of the inventive compositions as pesticides in particular for controlling phytopathogenic fungi as detailled herein and preparations or compositions comprising them. The invention furthermore also relates to seed comprising the compositions. The invention furthermore also relates to methods for controlling pests, in particular phytopathogenic fungi as detailled herein, wherein the fungi or the materials, plants, the soil or seed to be protected from fungal attack are treated with an effective amount of a compositions according to the invention. The invention furthermore also relates to processes for preparing the compositions according to the invention.
With a view to reducing the application rates and broadening the activity spectrum of the known compounds, it was an object of the present invention to provide compositions which, at a reduced total amount of active compounds applied, show improved activity against important pests, in particular phythopathogenic fungi, in particular for certain indications. It was a further object to provide for compositions that are useful for the control of specific pathogens in specific important crops that are often susceptible to the attack of pathogens.
Accordingly we have found the compositions and uses defined at the outset and in the following description.
The compounds I (component I) can be obtained by various routes in analogy to prior art processes known (cf. J.Agric. Food Chem. (2009) 57, 4854-4860; EP 0 275 955 A1 ; DE 40 03 180 A1 ; EP 0 1 13 640 A2; EP 0 126 430 A2). Furthermore, compounds I (component I), its preparation and use in crop protection are described in WO 2013/007767
(PCT/EP2012/063626), WO 2013/024076 (PCT/EP2012/065835), WO 2013/024075
(PCT/EP2012/065834), ), WO 2013/024077 (PCT/EP2012/065836), WO 2013/024081 (PCT/EP2012/065848), WO 2013/024080 (PCT/EP2012/065847), WO 2013/024083
(PCT/EP2012/065852) WO 2013/010862 (PCT/EP2012/063526), WO 2013/010894
(PCT/EP2012/063635), WO 2013/010885 (PCT/EP2012/063620), WO 2013/024082
(PCT/EP2012/065850), which also disclose certain compositions with other active
compounds. Owing to the basic character of their nitrogen atoms, the component I, i.e in particular compound 1-1 , I-2, I-3, I-4, I-5, I-6, I-7, I-8, I-9, 1-10, 1-1 1 , 1-12, 1-13, 1-14, 1-15, 1-16, 1-17, 1-18, 1-19, I-20, 1-21 , I-22, I-23, I-24, I-25, I-26, I-27, I-28, I-29, I-30 and 1-31 or any group of compounds I detailled above, is capable of forming salts or adducts with inorganic or organic acids or with metal ions, in particular salts with inorganic acids.
1-1 : 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol
Figure imgf000005_0001
1- -[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1 -yl)ethanol
Figure imgf000005_0002
I- -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol
Figure imgf000005_0003
I-4: 1 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1■
yl)ethanol
Figure imgf000005_0004
I-5: 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 -yl)butan-2-
Figure imgf000005_0005
I-6: 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pent-3-ynyl]-1 ,2,4-triazole
Figure imgf000005_0006
I-7: 2- 4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol
Figure imgf000005_0007
I-8: 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-cyclopropyl-2-methoxy-ethyl]-1 ,2,4-triazole
Figure imgf000005_0008
I-9: 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy-propyl]-1 ,2,4-triazole
Figure imgf000005_0009
- -[2-chloro-4-(4-chlorophenoxy)phenyl]-3,3-dimethyl-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol
Figure imgf000006_0001
-1 1 : 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-cyclopropyl-2-methoxy-ethyl]- 1 2,4-triazole
Figure imgf000006_0002
-12: 2-[2-trifluoromethyl-4-(4-chlorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 -yl)propan- -ol
Figure imgf000006_0003
-13: 1 - 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy-butyl]1 ,2,4-triazole
Figure imgf000006_0004
-14: 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol
Figure imgf000006_0005
-15: 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy-pent-3-ynyl]-1 ,2,4- triazole
Figure imgf000006_0006
-16: 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)but-3-yn-2-ol
Figure imgf000006_0007
-17 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol:
Figure imgf000006_0008
1-18 2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol:
Figure imgf000007_0001
1-19 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol:
Figure imgf000007_0002
I-20 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-propyl]-1 ,2,4-triazole:
Figure imgf000007_0003
1-21 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-butyl]-1 ,2,4-triazole:
Figure imgf000007_0004
I-22 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pentyl]-1 ,2,4-triazole:
Figure imgf000007_0005
I-23 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 ,1 ,1 -trifluoro-3-(1 ,2,4-triazol-1 -yl)propan-2-ol
Figure imgf000007_0006
I-24 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-fluoro-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol hydrochloride:
Figure imgf000007_0007
1-25 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-4-yn-2-ol:
Figure imgf000008_0001
-26 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 -yl)propan-2-ol:
Figure imgf000008_0002
I-27 2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 -yl)propan-2-ol:
Figure imgf000008_0003
I-28 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pentan-2-ol:
Figure imgf000008_0004
I-29 2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1 ,2,4-triazol-1 -yl)propan-2-ol:
Figure imgf000008_0005
I-30 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol:
Figure imgf000008_0006
and
1-31 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pentan-2-ol:
Figure imgf000009_0001
Examples of inorganic acids are hydrohalic acids, such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, carbonic acid, sulfuric acid, phosphoric acid and nitric acid.
Suitable organic acids are, for example, formic acid and alkanoic acids, such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, and also glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid and other arylcarboxylic acids, cinnamic acid, oxalic acid, alkylsulfonic acids (sulfonic acids having straight-chain or branched alkyl radicals of 1 to 20 carbon atoms), arylsulfonic acids or aryldisulfonic acids (aromatic radicals, such as phenyl and naphthyl, which carry one or two sulfonic acid groups), alkylphosphonic acids (phosphonic acids having straight-chain or branched alkyl radicals with 1 to 20 carbon atoms), arylphosphonic acids or aryldiphosphonic acids
(aromatic radicals, such as phenyl and naphthyl, which carry one or two phosphoric acid radicals), where the alkyl or aryl radicals may carry further substituents, for example p- toluenesulfonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2- acetoxybenzoic acid etc. Suitable metal ions are in particular the ions of the elements of the second main group, in particular calcium and magnesium, of the third and fourth main group, in particular aluminum, tin and lead, and also of the elements of transition groups one to eight, in particular chromium, manganese, iron, cobalt, nickel, copper, zinc, and others. Particular preference is given to the metal ions of the elements of transition groups of the fourth period. The metals can be present in the various valencies that they can assume.
Components I comprise chiral centers and they are generally obtained in the form of racemates. The R- and S-enantiomers of the compounds according to the invention can be separated and isolated in pure form with methods known by the skilled person, e.g. by using chiral HPLC. Suitable for use as antimicrobial agents are both the enantiomers and compositions thereof. This applies correspondingly to the compositions. Furthermore, components I can be present in different crystal modifications, which may differ in biological activity.
In particular, in each case, a racemic composition is present. Furthermore, any other proportions of the (R)-enantiomer and the (S)-enantiomer may be present according to the present invention. This applies to every composition detained herein.
According to one embodiment of the present invention, component I is compound 1-1.
Compound 1-1 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-1 .
According to one specific embodiment, the compound 1-1 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-1 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (R)-l-1 : (R) -2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3- yn-2-ol; Compound (S)-l-1 : (S) -2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pent-3-yn-2-ol.According to a further embodiment of the present invention, component I is compound I-2. Compound I-2 may be present as racemic composition of the (R)-enantiomer and (S)-enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-2.
According to one specific embodiment, the compound I-2 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-2 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (R)-l-2: (R)-1 -[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol- 1 -yl)ethanol; compound (S)-l-2: (S)-1 -[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -cyclopropyl-2- (1 ,2,4-triazol-1 -yl)ethanol.
According to still a further embodiment of the present invention, component I is compound I- 3. Compound I-3 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-3.
According to one specific embodiment, the compound I-3 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-3 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (R)-l-3: (R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol; compound (S)-l-3: (S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 - (1 ,2,4-triazol-1 -yl)propan-2-ol. According to still a further embodiment of the present invention, component I is compound I-
4. Compound I-4 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-4.
According to one specific embodiment, the compound I-4 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-4 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (R)-l-4: (R)-1 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl-2- (1 ,2,4-triazol-1 -yl)ethanol; compound (S)-l-4: (S)-1-[4-(4-chlorophenoxy)-2- (trifluoromethyl)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1 -yl)ethanol.
According to still a further embodiment of the present invention, component I is compound I-
5. Compound I-5 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-5.
According to one specific embodiment, the compound I-5 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-5 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (R)-l-5: (R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1 -(1 ,2,4- triazol-1 -yl)butan-2-ol; compound (S)-l-5: (S)-2-[4-(4-chlorophenoxy)-2- (trifluoromethyl)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1-yl)butan-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
6. Compound I-6 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-6.
According to one specific embodiment, the compound I-6 is provided and used as (R)- enantiomer with an enantomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%. According to a further specific embodiment, the compound I-6 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-6: (S)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pent-3-ynyl]- 1 ,2,4-triazole; compound (R)-l-6: (R)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy- pent-3-ynyl]-1 ,2,4-triazole.
According to still a further embodiment of the present invention, component I is compound I-
7. Compound I-7 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-7.
According to one specific embodiment, the compound I-7 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-7 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
compound (S)-l-7: (S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol; compound (R)-l-7: (R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 - (1 ,2,4-triazol-1 -yl)butan-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
8. Compound I-8 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-8.
According to one specific embodiment, the compound I-8 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-8 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-8: (S)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-cyclopropyl-2-methoxy- ethyl]-1 ,2,4-triazole; Compound (R)-l-8: (R)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2- cyclopropyl-2-methoxy-ethyl]-1 ,2,4-triazole.
According to still a further embodiment of the present invention, component I is compound I-
9. Compound I-9 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-9.
According to one specific embodiment, the compound I-9 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-9 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-9: (S)-1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy- propyl]-1 ,2,4-triazole; compound (R)-l-9: (R)-1 -[2-[4-(4-chlorophenoxy)-2- (trifluoromethyl)phenyl]-2-methoxy-propyl]-1 ,2,4-triazole.
According to still a further embodiment of the present invention, component I is compound I- 10. Compound 1-10 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-10.
According to one specific embodiment, the compound 1-10 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-10 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-10: (S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3,3-dimethyl-1 -(1 ,2,4-triazol- 1 -yl)butan-2-ol; compound (R)-l-10: (R)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3,3-dimethyl- 1 -(1 ,2,4-triazol-1 -yl)butan-2-ol.
According to still a further embodiment of the present invention, component I is compound I- 1 1 . Compound 1-1 1 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-1 1 .
According to one specific embodiment, the compound 1-1 1 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-1 1 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-1 1 : (S)-1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-cyclopropyl-2- methoxy-ethyl]-1 ,2,4-triazole; compound (R)-l-1 1 : (R)-1 -[2-[4-(4-chlorophenoxy)-2- (trifluoromethyl)phenyl]-2-cyclopropyl-2-methoxy-ethyl]-1 ,2,4-triazole.
According to still a further embodiment of the present invention, component I is compound I-
12. Compound 1-12 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-12.
According to one specific embodiment, the compound 1-12 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-12 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-12: (S)-2-[2-trifluoromethyl-4-(4-chlorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4- triazol-1 -yl)propan-2-ol; compound (R)-l-12: (R)-2-[2-trifluoromethyl-4-(4- chlorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 -yl)propan-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
13. Compound 1-13 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-13.
According to one specific embodiment, the compound 1-13 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-13 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-13: (S)-1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy- butyl]1 ,2,4-triazole; Compound (R)-l-13: (R)-1 -[2-[4-(4-chlorophenoxy)-2- (trifluoromethyl)phenyl]-2-methoxy-butyl]1 ,2,4-triazole.
According to still a further embodiment of the present invention, component I is compound I-
14. Compound 1-14 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-14. According to one specific embodiment, the compound 1-14 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-14 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-14: (S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pent-3-yn-2-ol; compound (R)-l-14: (R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]- 1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
15. Compound 1-15 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-15.
According to one specific embodiment, the compound 1-15 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-15 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-15: (S)-1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy-pent- 3-ynyl]-1 ,2,4-triazole; Compound (R)-l-15: (R)-1 -[2-[4-(4-chlorophenoxy)-2- (trifluoromethyl)phenyl]-2-methoxy-pent-3-ynyl]-1 ,2,4-triazole.
According to still a further embodiment of the present invention, component I is compound I-
16. Compound 1-16 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-16.
According to one specific embodiment, the compound 1-16 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-16 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%. Compound (S)-l-16: (S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)but-3-yn-2-ol; compound (R)-l-16: (R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 - (1 ,2,4-triazoM -yl)but-3-yn-2-ol.
According to one embodiment of the present invention, component I is compound 1-17.
Compound 1-17 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-17.
According to one specific embodiment, the compound 1-17 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-17 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (R)-l-17: (R)-12-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol; compound (S)-l-4: (S)-12-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4- triazol-1 -yl)propan-2-ol.
According to a further embodiment of the present invention, component I is compound 1-18. Compound 1-18 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-18.
According to one specific embodiment, the compound 1-18 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-18 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-18: (S)-2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan- 2-ol; Compound (R)-l-18: (R)-2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol.
According to still a further embodiment of the present invention, component I is compound I- 19. Compound 1-19 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-19.
According to one specific embodiment, the compound 1-19 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-19 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compounds (S)-l-19: (S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol; Compounds (R)-l-19: (R)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1 - (1 ,2,4-triazol-1 -yl)butan-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
20. Compound I-20 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-20.
According to one specific embodiment, the compound I-20 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-20 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-20: (S)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-propyl]-1 ,2,4- triazole; Compound (R)-l-20: (R)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy- propyl]-1 ,2,4-triazole.
According to still a further embodiment of the present invention, component I is compound I-
21 . Compound 1-21 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-21.
According to one specific embodiment, the compound 1-21 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-21 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-21 : (S)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-butyl]-1 ,2,4- triazole; Compound (R)-l-21 : (R)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-butyl]- 1 ,2,4-triazole. According to still a further embodiment of the present invention, component I is compound I-
22. Compound I-22 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-22.
According to one specific embodiment, the compound I-22 is provided and used as (R)- enantiomer with an enantomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-22 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-22: (S)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pentyl]-1 ,2,4- triazole; Compound (R)-l-22: (R)-1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy- pentyl]-1 ,2,4-triazole.
According to still a further embodiment of the present invention, component I is compound I-
23. Compound I-23 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-23.
According to one specific embodiment, the compound I-23 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-23 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-23: (S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 ,1 ,1 -trifluoro-3-(1 ,2,4- triazol-1 -yl)propan-2-ol; Compound (R)-l-23: (R)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]- 1 ,1 ,1 -trifluoro-3-(1 ,2,4-triazol-1 -yl)propan-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
24. Compound I-24 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-24.
According to one specific embodiment, the compound I-24 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%. According to a further specific embodiment, the compound I-24 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-24: (S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-fluoro-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol hydrochloride; Compound (R)-l-24: (R)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]- 3-fluoro-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol hydrochloride.
According to still a further embodiment of the present invention, component I is compound I-
25. Compound I-25 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-25.
According to one specific embodiment, the compound I-25 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-25 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-25: (S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-4- yn-2-ol; Compound (R)-l-25: (R)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pent-4-yn-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
26. Compound I-26 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-26.
According to one specific embodiment, the compound I-26 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-26 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-26: (S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 - yl)propan-2-ol; Compound (R)-l-26: (R)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -methoxy-3- (1 ,2,4-triazol-1 -yl)propan-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
27. Compound I-27 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-27.
According to one specific embodiment, the compound I-27 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-27 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-27: (S)-2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-1 - yl)propan-2-ol; Compound (R)-l-27: (R)-2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -methoxy-3- (1 ,2,4-triazol-1 -yl)propan-2-ol.
According to still a further embodiment of the present invention, component I is compound I- 28. Compound I-28 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-28.
According to one specific embodiment, the compound I-28 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-28 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-28: (S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pentan-2-ol; Compound (R)-l-28: (R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 - (1 ,2,4-triazoM -yl)pentan-2-ol.
According to still a further embodiment of the present invention, component I is compound I- 29. Compound I-29 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-29.
According to one specific embodiment, the compound I-29 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-29 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-29: (S)-2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol; Compound (R)-l-29: (R)-2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1 - (1 ,2,4-triazol-1 -yl)propan-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
30. Compound I-30 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of I-30.
According to one specific embodiment, the compound I-30 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound I-30 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-30: (S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)butan-2- ol; Compound (R)-l-30: (R)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol.
According to still a further embodiment of the present invention, component I is compound I-
31 . Compound 1-31 may be present as racemic composition of the (R)-enantiomer and (S)- enantiomer, but the (R)-enantiomer and the (S)-enantiomer may also be present in any other proportion, for example the pure enantiomer (R) or the pure enantiomer (S) of 1-31.
According to one specific embodiment, the compound 1-31 is provided and used as (R)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
According to a further specific embodiment, the compound 1-31 is provided and used as (S)- enantiomer with an enantiomeric excess (e.e.) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, yet more preferably at least 98% and most preferably at least 99%.
Compound (S)-l-31 : (S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pentan- 2-ol; Compound (R)-l-31 : (R)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pentan-2-ol.
According to one further embodiment of the present invention, component I is selected from compounds 1-1 , I-2, I-3, I-4, I-5, I-6, I-7, I-8, I-9, 1-1 1 , 1-13, 1-14, 1-15 and 1-16. According to a more particular embodiment of the present invention, component I is selected from compounds 1-1 , I-2, I-6 and I-8. According to another more particular embodiment of the present invention, component I is selected from compounds I-3, I-4, I-5, I-7, I-9, 1-1 1 , 1-13, I- 14, 1-15 and 1-16.
According to still a further embodiment of the present invention, component I is selected from compounds 1-1 , I-2, I-3, I-4 and I-5, more specifically selected from 1-1 , I-3, I-4 and I-5.
According to still a further embodiment of the present invention, component I is selected from compounds I-3, I-4 and I-5.
The preparation of component II and their action against harmful fungi are known (cf.:
http://www.alanwood.net/pesticides/) and they are generally commercially available.
Commercially available active compounds can be found, for example, in The Pesticide Manual, 14th Edition, British Crop Protection Council (2006) and other publications.
oxathiapiprolin (11-1 ): 1 -(4-{4-[(5RS)-5-(2,6-difluorophenyl)-4,5-dihydro-1 ,2-oxazol-3-yl]-1 ,3- thiazol-2-yl}-1 -piperidyl)-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1 -yl]ethanone
triadimenol (II-2): (1 RS,2RS;1 RS,2SR)-1 -(4-chlorophenoxy)-3,3-dimethyl-1 -(1 H-1 ,2,4-triazol- 1 -yl)butan-2-ol
sulfoxaflor (II-3): [methyl(oxo){1 -[6-(trifluoromethyl)-3-pyridyl]ethyl}-A6- sulfanylidene]cyanamide
methiocarb (II-4): 4-methylthio-3,5-xylyl methylcarbamate
cypermethrin (II-5): (RS)-a-cyano-3-phenoxybenzyl (1 RS,3RS;1 RS,3SR)-3-{2,2- dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate or (RS)-ocyano-3-phenoxybenzyl (1 RS)- c/s-frans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
thiodicarb (II-6): (3£Z,12£Z)-3,7,9,13-tetramethyl-5,1 1 -dioxa-2,8, 14-trithia-4,7,9, 12- tetraazapentadeca-3,12-diene-6,10-dione
triflumezopyrim (mesoionic) (II-7): 3,4-dihydro-2,4-dioxo-1 -(pyrimidin-5-ylmethyl)-3-(a,a,a- trifluoro-m-tolyl)-2/-/-pyrido[1 ,2-a]pyrimidin-1 -ium-3-ide
flupyradifurone (II-8): 4-[(6-chloro-3-pyridylmethyl)(2,2-difluoroethyl)amino]furan-2(5/-/)-one
In a further embodiment, component II is selected the group of oxathiapiprolin (11-1 );
triadimenol (II-2); sulfoxaflor (II-3); methiocarb (II-4); thiodicarb (II-6); triflumezopyrim
(Mesoionic) (II-7) and flupyradifurone (II-8).
In one embodiment, component II is selected from the group of oxathiapiprolin (11-1 );
triadimenol (II-2); sulfoxaflor (II-3); methiocarb (II-4) and triflumezopyrim (Mesoionic) (II-7).
In the following, the inventive compositions and their preferred uses are further described. In each case, according to the present invention, the use of the composition for controlling a particular pest, in particular phytopathogenic fungus is also meant to encompass the respective method for controlling the particular pest, in particular phytopathogenic fungi, wherein the fungi or the materials, plants, the soil or seed to be protected from attack are treated with an effective amount of a composition as defined herein.
According to a specific embodiment of the invention, only two active compounds as defined are present in the inventive compositions (herein also called "binary compositions"). The composition may, of course, contain any kind of additive or the like as detained below in order to provide a formulation suitable for use in agriculture.
The weight ratio of component I to component II depends from the properties of the active substances used and is usually in the range of from 1:1000 to 1000:1, more particularly 1 :500 to 500:1. The weight ratio of component I to component II may preferably be in the range of from 1:100 to 100:1, frequently in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, particularly preferably in the range of from 1:10 to 10:1, in particular in the range of from 1:3 to 3:1. It may also be preferable for the weight ratio to be in the range of from 1 :2 to 2:1.
According to still further embodiments of the two-component compositions according to the invention, the weight ratio of component I to component II usually is in the range of from 1:1 to 1:100, regularly in the range of from 1:1 to 1:50, preferably in the range of from 1:1 to 1:20, more preferably in the range of from 1:1 to 1:10, even more preferably in the range of from 1:1 to 1:4 and in particular in the range of from 1:1 to 1:2.
According to one embodiment, two-component compositions according to the invention may preferably have weight ratios of compound I versus compound II in the range of from 1000:1 to 1:1, often in the range of from 100:1 to 1:1, regularly in the range of from 50:1 to 1:1, preferably in the range of from 20:1 to 1:1, more preferably in the range of from 10:1 to 1:1, even more preferably in the range of from 4:1 to 1:1 and in particular in the range of from 2:1 to 1:1.
The specific compositions of the invention are compiled in Table B1, wherein each row corresponds to one embodiment of the compositions according to the invention, i.e. one specific individualized composition. According to one specific aspect, these are binary compositions which each only contain these two components as active compounds.
Furthermore, also every combination of the compositions individualized in this table represent embodiments of the present invention.
Table B1 : Two-component compositions B1-1 to B1-248 comprising one component I and a component II, in particular binary compositions containing the respective component I and II as only active ingredients:
I = component I selected from compounds 1-1 to 1-31
II = oxathiapiprolin (11-1); triadimenol (II-2); sulfoxaflor (II-3); methiocarb (II-4); cypermethrin (II-5); thiodicarb (II-6); triflumezopyrim (mesoionic) (II-7) and flupyradifurone (II-8).
compoI II compoI II compoI II sition sition sition
B1-1 1-1 11-1 B1-7 I -7 11-1 B1-13 1-13 11-1
B1-2 I-2 11-1 B1-8 I-8 11-1 B1-14 1-14 11-1
B1-3 I-3 11-1 B1-9 I-9 11-1 B1-15 1-15 11-1
B1-4 I-4 11-1 B1-10 1-10 11-1 B1-16 1-16 11-1
B1-5 I-5 11-1 B1-11 1-11 11-1 B1-17 1-17 11-1
B1-6 I-6 11-1 B1-12 1-12 11-1 B1-18 1-18 11-1 compoI II compoI II compoI II sition sition sition
B1-19 1-19 11-1 B1-59 I-28 II-2 B1-99 I-6 II-4
B1-20 I-20 11-1 B1-60 I-29 II-2 B1-100 I -7 II-4
B1-21 1-21 11-1 B1-61 I-30 II-2 B1-101 I-8 II-4
B1-22 I-22 11-1 B1-62 1-31 II-2 B1-102 I-9 II-4
B1-23 I-23 11-1 B1-63 1-1 II-3 B1-103 1-10 II-4
B1-24 I-24 11-1 B1-64 I-2 II-3 B1-104 1-11 II-4
B1-25 I-25 11-1 B1-65 I-3 II-3 B1-105 1-12 II-4
B1-26 I-26 11-1 B1-66 I-4 II-3 B1-106 1-13 II-4
B1-27 I-27 11-1 B1-67 I-5 II-3 B1-107 1-14 II-4
B1-28 I-28 11-1 B1-68 I-6 II-3 B1-108 1-15 II-4
B1-29 I-29 11-1 B1-69 I -7 II-3 B1-109 1-16 II-4
B1-30 I-30 11-1 B1-70 I-8 II-3 B1-110 1-17 II-4
B1-31 1-31 11-1 B1-71 I-9 II-3 B1-111 1-18 II-4
B1-32 1-1 II-2 B1-72 1-10 II-3 B1-112 1-19 II-4
B1-33 I-2 II-2 B1-73 1-11 II-3 B1-113 I-20 II-4
B1-34 I-3 II-2 B1-74 1-12 II-3 B1-114 1-21 II-4
B1-35 I-4 II-2 B1-75 1-13 II-3 B1-115 I-22 II-4
B1-36 I-5 II-2 B1-76 1-14 II-3 B1-116 I-23 II-4
B1-37 I-6 II-2 B1-77 1-15 II-3 B1-117 I-24 II-4
B1-38 I -7 II-2 B1-78 1-16 II-3 B1-118 I-25 II-4
B1-39 I-8 II-2 B1-79 1-17 II-3 B1-119 I-26 II-4
B1-40 I-9 II-2 B1-80 1-18 II-3 B1-120 I-27 II-4
B1-41 1-10 II-2 B1-81 1-19 II-3 B1-121 I-28 II-4
B1-42 1-11 II-2 B1-82 I-20 II-3 B1-122 I-29 II-4
B1-43 1-12 II-2 B1-83 1-21 II-3 B1-123 I-30 II-4
B1-44 1-13 II-2 B1-84 I-22 II-3 B1-124 1-31 II-4
B1-45 1-14 II-2 B1-85 I-23 II-3 B1-125 1-1 II-5
B1-46 1-15 II-2 B1-86 I-24 II-3 B1-126 I-2 II-5
B1-47 1-16 II-2 B1-87 I-25 II-3 B1-127 I-3 II-5
B1-48 1-17 II-2 B1-88 I-26 II-3 B1-128 I-4 II-5
B1-49 1-18 II-2 B1-89 I-27 II-3 B1-129 I-5 II-5
B1-50 1-19 II-2 B1-90 I-28 II-3 B1-130 I-6 II-5
B1-51 I-20 II-2 B1-91 I-29 II-3 B1-131 I -7 II-5
B1-52 1-21 II-2 B1-92 I-30 II-3 B1-132 I-8 II-5
B1-53 I-22 II-2 B1-93 1-31 II-3 B1-133 I-9 II-5
B1-54 I-23 II-2 B1-94 1-1 II-4 B1-134 1-10 II-5
B1-55 I-24 II-2 B1-95 I-2 II-4 B1-135 1-11 II-5
B1-56 I-25 II-2 B1-96 I-3 II-4 B1-136 1-12 II-5
B1-57 I-26 II-2 B1-97 I-4 II-4 B1-137 1-13 II-5
B1-58 I-27 II-2 B1-98 I-5 II-4 B1-138 1-14 II-5 compoI II compoI II compoI II sition sition sition
B1-139 1-15 II-5 B1-176 1-21 II-6 B1-213 I-27 II-7
B1-140 1-16 II-5 B1-177 I-22 II-6 B1-214 I-28 II-7
B1-141 1-17 II-5 B1-178 I-23 II-6 B1-215 I-29 II-7
B1-142 1-18 II-5 B1-179 I-24 II-6 B1-216 I-30 II-7
B1-143 1-19 II-5 B1-180 I-25 II-6 B1-217 1-31 II-7
B1-144 I-20 II-5 B1-181 I-26 II-6 B1-218 1-1 II-8
B1-145 1-21 II-5 B1-182 I-27 II-6 B1-219 I-2 II-8
B1-146 I-22 II-5 B1-183 I-28 II-6 B 1-220 I-3 II-8
B1-147 I-23 II-5 B1-184 I-29 II-6 B1-221 I-4 II-8
B1-148 I-24 II-5 B1-185 I-30 II-6 B 1-222 I-5 II-8
B1-149 I-25 II-5 B1-186 1-31 II-6 B 1-223 I-6 II-8
B1-150 I-26 II-5 B1-187 1-1 II-7 B 1-224 I -7 II-8
B1-151 I-27 II-5 B1-188 I-2 II-7 B 1-225 I-8 II-8
B1-152 I-28 II-5 B1-189 I-3 II-7 B 1-226 I-9 II-8
B1-153 I-29 II-5 B1-190 I-4 II-7 B 1-227 1-10 II-8
B1-154 I-30 II-5 B1-191 I-5 II-7 B 1-228 1-11 II-8
B1-155 1-31 II-5 B1-192 I-6 II-7 B 1-229 1-12 II-8
B1-156 1-1 II-6 B1-193 I -7 II-7 B1-230 1-13 II-8
B1-157 I-2 II-6 B1-194 I-8 II-7 B1-231 1-14 II-8
B1-158 I-3 II-6 B1-195 I-9 II-7 B 1-232 1-15 II-8
B1-159 I-4 II-6 B1-196 1-10 II-7 B1-233 1-16 II-8
B1-160 I-5 II-6 B1-197 1-11 II-7 B 1-234 1-17 II-8
B1-161 I-6 II-6 B1-198 1-12 II-7 B1-235 1-18 II-8
B1-162 I -7 II-6 B1-199 1-13 II-7 B1-236 1-19 II-8
B1-163 I-8 II-6 B1-200 1-14 II-7 B1-237 I-20 II-8
B1-164 I-9 II-6 B1-201 1-15 II-7 B1-238 1-21 II-8
B1-165 1-10 II-6 B 1-202 1-16 II-7 B1-239 I-22 II-8
B1-166 1-11 II-6 B1-203 1-17 II-7 B 1-240 I-23 II-8
B1-167 1-12 II-6 B 1-204 1-18 II-7 B1-241 I-24 II-8
B1-168 1-13 II-6 B1-205 1-19 II-7 B 1-242 I-25 II-8
B1-169 1-14 II-6 B1-206 I-20 II-7 B 1-243 I-26 II-8
B1-170 1-15 II-6 B1-207 1-21 II-7 B 1-244 I-27 II-8
B1-171 1-16 II-6 B1-208 I-22 II-7 B 1-245 I-28 II-8
B1-172 1-17 II-6 B1-209 I-23 II-7 B 1-246 I-29 II-8
B1-173 1-18 II-6 B1-210 I-24 II-7 B 1-247 I-30 II-8
B1-174 1-19 II-6 B1-211 I-25 II-7 B 1-248 1-31 II-8
B1-175 I-20 II-6 B1-212 I-26 II-7
The weight ratio of component I to component II in the compositions B1-1 to B1-248 depends from the properties of the active substances used and is usually in the range of from 1 :1000 to 1000:1 , more particularly 1 :500 to 500:1 . The weight ratio of component I to component II in the compositions B1 -1 to B1 -248 may preferably be in the range of from 1 :100 to 100:1 , frequently in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , particularly preferably in the range of from 1 :10 to 10:1 , in particular in the range of from 1 :3 to 3:1 . It may also be preferable for the weight ratio to be in the range of from 1 :2 to 2:1 .
According to still further embodiments of the compositions B1 -1 to B1 -248 according to the invention, the weight ratio of component I to component II usually is in the range of from 1 :1 to 1 :100, regularly in the range of from 1 :1 to 1 :50, preferably in the range of from 1 :1 to 1 :20, more preferably in the range of from 1 :1 to 1 :10, even more preferably in the range of from 1 :1 to 1 :4 and in particular in the range of from 1 :1 to 1 :2.
According to one further embodiment, the compositions B1 -1 to B1 -248 according to the invention may preferably have weight ratios of component I versus compound II in the range of from 1000:1 to 1 :1 , often in the range of from 100:1 to 1 :1 , regularly in the range of from 50:1 to 1 :1 , preferably in the range of from 20:1 to 1 :1 , more preferably in the range of from 10:1 to 1 :1 , even more preferably in the range of from 4:1 to 1 :1 and in particular in the range of from 2:1 to 1 :1.
One embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1000:1 to 1 :1000.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 500:1 to 1 :500.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 100:1 to 1 :100.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :100 to 100:1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :50 to 50:1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :20 to 20:1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :10 to 10:1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :3 to 3:1.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :2 to 2:1.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1000:1 to 1 :1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 100:1 to 1 :1 . One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 50:1 to 1 :1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 20:1 to 1 :1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 10:1 to 1 :1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 4:1 to 1 :1 .
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 2:1 to 1 :1.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1000.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :100.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :50.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :20.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :10.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :4.
One further embodiment of the invention relates to any one of compositions B1 -1 to B1 -248 wherein the weight ratio of component I to component II is from 1 :1 to 1 :2.
As detailed above, the components I contain chirality centers and may, therefore, be present as racemic mixtures, as pure enantiomers or in the two enantiomers of one component I may be present in any ratio (S):(R).
According to particular embodiments of the invention, the respective component I is present as (S) enantiomer. According to particular embodiments of the invention, the respective component I is present as (R) enantiomer. According to one specific aspect, these are binary compositions which each only contain these two components as active compounds.
The compositions according to the invention are suitable as fungicides. They are
distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, including soil-borne fungi, which derive especially from the classes of the
Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti). Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.
The compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e. g. apples, pears, plums, peaches, almonds, cherries,
strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rape, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e. g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants.
Preferably the inventive compositions are used for controlling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
The term "plant propagation material" is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.
Preferably, treatment of plant propagation materials with the inventive combination of pesticides I and pesticides II and compositions thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.
The term "cultivated plants" is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://cera-gmc.org/, see GM crop database therein). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties. Plants that have been modified by breeding, mutagenesis or genetic engineering, e. g. have been rendered tolerant to applications of specific classes of herbicides, such as
hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors; acetolactate synthase (ALS) inhibitors, such as sulfonyl ureas (see e. g. US 6,222,100, WO 01/82685, WO 00/26390, WO 97/41218, WO 98/02526, WO 98/02527, WO 04/106529, WO 05/20673, WO 03/14357, WO 03/13225, WO 03/14356, WO 04/16073) or imidazolinones (see e. g. US 6,222,100, WO 01/82685, WO 00/026390, WO 97/41218, WO 98/002526, WO 98/02527,
WO 04/106529, WO 05/20673, WO 03/014357, WO 03/13225, WO 03/14356,
WO 04/16073); enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate (see e. g. WO 92/00377); glutamine synthetase (GS) inhibitors, such as glufosinate (see e. g. EP-A 242 236, EP-A 242 246) or oxynil herbicides (see e. g.
US 5,559,024) as a result of conventional methods of breeding or genetic engineering.
Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), e. g. Clearfield® summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox. Genetic engineering methods have been used to render cultivated plants such as soybean, cotton, corn, beets and rape, tolerant to herbicides such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady® (glyphosate-tolerant, Monsanto, U.S.A.) and LibertyLink® (glufosinate-tolerant, Bayer CropScience, Germany).
Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus Bacillus, particularly from Bacillus thuringiensis, such as δ-endotoxins, e. g. CrylA(b), CrylA(c), CrylF, CrylF(a2), CryllA(b), CrylllA, CrylllB(bl ) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1 , VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp. or Xenorhabdus spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins; toxins produced by fungi, such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3- hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors
(helicokinin receptors); stilbene synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins.
Hybrid proteins are characterized by a new combination of protein domains, (see, e. g.
WO 02/015701 ). Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, e. g., in EP-A 374 753, WO 93/007278,
WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/18810 und WO 03/52073. The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of arthropods, especially to beetles (Coeloptera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda). Genetically modified plants capable to synthesize one or more insecticidal proteins are, e. g., described in the publications mentioned above, and some of which are commercially available such as YieldGard® (corn cultivars producing the CrylAb toxin), YieldGard® Plus (corn cultivars producing CrylAb and Cry3Bb1 toxins),
Starlink® (corn cultivars producing the Cry9c toxin), Herculex® RW (corn cultivars producing Cry34Ab1 , Cry35Ab1 and the enzyme Phosphinothricin-A/-Acetyltransferase [PAT]);
NuCOTN® 33B (cotton cultivars producing the CrylAc toxin), Bollgard® I (cotton cultivars producing the CrylAc toxin), Bollgard® II (cotton cultivars producing CrylAc and Cry2Ab2 toxins); VIPCOT® (cotton cultivars producing a VIP-toxin); NewLeaf® (potato cultivars producing the Cry3A toxin); Bt-Xtra®, NatureGard®, KnockOut®, BiteGard®, Protecta®, Bt1 1 (e. g. Agrisure® CB) and Bt176 from Syngenta Seeds SAS, France, (corn cultivars producing the CrylAb toxin and PAT enyzme), MIR604 from Syngenta Seeds SAS, France (corn cultivars producing a modified version of the Cry3A toxin, c.f. WO 03/018810), MON 863 from Monsanto Europe S.A., Belgium (corn cultivars producing the Cry3Bb1 toxin), IPC 531 from Monsanto Europe S.A., Belgium (cotton cultivars producing a modified version of the CrylAc toxin) and 1507 from Pioneer Overseas Corporation, Belgium (corn cultivars producing the Cry1 F toxin and PAT enzyme).
Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens. Examples of such proteins are the so-called "pathogenesis-related proteins" (PR proteins, see, e. g. EP-A 392 225), plant disease resistance genes (e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora). The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.
Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environmental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.
Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, e. g. oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera® rape, DOW Agro Sciences, Canada).
Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora® potato, BASF SE, Germany). The inventive compositions are particularly suitable for controlling the following plant diseases:
Albugo spp. (white rust) on ornamentals, vegetables (e. g. A. Candida) and sunflowers (e. g. A. tragopogonis); Altemaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A.
alternata), tomatoes (e. g. A. solani or A. alternata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e. g. A. tritici
(anthracnose) on wheat and A. hordei on barley; Bipolaris and Drechslera spp. (teleomorph: Cochliobolus spp.) on corn (e. g. D. maydis), cereals (e. g. B. sorokiniana: spot blotch), rice (e. g. B. oryzae) and turfs; Blumeria (formerly Erysiphe) graminis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botryotinia fuckeliana: grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Bremia lactucae (downy mildew) on lettuce;
Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spots) on corn, rice, sugar beets (e. g. C. beticola), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. kikuchii) and rice; Cladosporium spp. on tomatoes (e. g. C. fulvum: leaf mold) and cereals, e. g. C. herbarum (black ear) on wheat; Claviceps purpurea (ergot) on cereals; Cochliobolus (anamorph: Helminthosporium of Bipolaris) spp. (leaf spots) on corn (C. carbonum), cereals (e. g. C. sativus, anamorph: B. sorokiniana) and rice (e. g. C. miyabeanus, anamorph: H. oryzae); Colletotrichum (teleomorph: Glomerella) spp. (anthracnose) on cotton (e. g. C.
gossypii), corn (e. g. C. graminicola), soft fruits, potatoes (e. g. C. coccodes: black dot), beans (e. g. C. lindemuthianum) and soybeans (e. g. C. truncatum or C. gloeosporioides); Corticium spp., e. g. C. sasakii (sheath blight) on rice; Corynespora cassiicola (leaf spots) on soybeans and ornamentals; Cycloconium spp., e. g. C. oleaginum on olive trees;
Cylindrocarpon spp. (e. g. fruit tree canker or young vine decline, teleomorph: Nectria or Neonectria spp.) on fruit trees, vines (e. g. C. liriodendri, teleomorph: Neonectria liriodendri: Black Foot Disease) and ornamentals; Dematophora (teleomorph: Rosellinia) necatrix (root and stem rot) on soybeans; Diaporthe spp., e. g. D. phaseolorum (damping off) on soybeans; Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formitiporia (syn. Phellinus) punctata, F.
mediterranea, Phaeomoniella chlamydospora (earlier Phaeoacremonium chlamydosporum), Phaeoacremonium aleophilum and/or Botryosphaeria obtusa; Elsinoe spp. on pome fruits (£. pyri), soft fruits (£. veneta: anthracnose) and vines (£. ampelina: anthracnose); Entyloma oryzae (leaf smut) on rice; Epicoccum spp. (black mold) on wheat; Erysiphe spp. (powdery mildew) on sugar beets (£. betae), vegetables (e. g. E. pisi), such as cucurbits (e. g. E.
cichoracearum), cabbages, rape (e. g. E. cruciferarum); Eutypa lata (Eutypa canker or dieback, anamorph: Cytosporina lata, syn. Libertella blepharis) on fruit trees, vines and ornamental woods; Exserohilum (syn. Helminthosporium) spp. on corn (e. g. E. turcicum); Fusarium (teleomorph: Gibberella) spp. (wilt, root or stem rot) on various plants, such as F. graminearum or F. culmorum (root rot, scab or head blight) on cereals (e. g. wheat or barley), F. oxysporum on tomatoes, F. solani (f. sp. glycines now syn. F. virguliforme ) and F.
tucumaniae and F. brasiliense each causing sudden death syndrome on soybeans, and F. verticillioides on corn; Gaeumannomyces graminis (take-all) on cereals (e. g. wheat or barley) and corn; Gibberella spp. on cereals (e. g. G. zeae) and rice (e. g. G. fujikuroi:
Bakanae disease); Glomerella cingulata on vines, pome fruits and other plants and G.
gossypii on cotton; Grainstaining complex on rice; Guignardia bidwellii (black rot) on vines; Gymnosporangium spp. on rosaceous plants and junipers, e. g. G. sabinae (rust) on pears; Helminthosporium spp. (syn. Drechslera, teleomorph: Cochliobolus) on corn, cereals and rice; Hemileia spp., e. g. H. vastatrix (coffee leaf rust) on coffee; Isariopsis clavispora (syn. Cladosporium vitis) on vines; Macrophomina phaseolina (syn. phaseoli) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink snow mold) on cereals (e. g. wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., e. g. M. laxa, M. fructicola and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, bananas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici, Septoria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (e. g. P. brassicae), rape (e. g. P. parasitica), onions (e. g. P. destructor), tobacco (P.
tabacina) and soybeans (e. g. P. manshurica); Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phialophora spp. e. g. on vines (e. g. P. tracheiphila and P. tetraspora) and soybeans (e. g. P. gregata: stem rot); Phoma lingam (root and stem rot) on rape and cabbage and P. betae (root rot, leaf spot and damping-off) on sugar beets;
Phomopsis spp. on sunflowers, vines (e. g. P. viticola: can and leaf spot) and soybeans (e. g. stem rot: P. phaseoli, teleomorph: Diaporthe phaseolorum); Physoderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsici), soybeans (e. g. P. megasperma, syn. P. sojae), potatoes and tomatoes (e. g. P. infestans: late blight) and broad-leaved trees (e. g. P.
ramorum: sudden oak death); Plasmodiophora brassicae (club root) on cabbage, rape, radish and other plants; Plasmopara spp., e. g. P. viticola (grapevine downy mildew) on vines and P. halstedii on sunflowers; Podosphaera spp. (powdery mildew) on rosaceous plants, hop, pome and soft fruits, e. g. P. leucotricha on apples; Polymyxa spp., e. g. on cereals, such as barley and wheat (P. graminis) and sugar beets (P. betae) and thereby transmitted viral diseases; Pseudocercosporella herpotrichoides (eyespot, teleomorph: Tapesia yallundae) on cereals, e. g. wheat or barley; Pseudoperonospora (downy mildew) on various plants, e. g. P. cubensis on cucurbits or P. humili on hop; Pseudopezicula tracheiphila (red fire disease or .rotbrenner', anamorph: Phialophora) on vines; Puccinia spp. (rusts) on various plants, e. g. P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye, and asparagus (e. g. P. asparagi); Pyrenophora (anamorph: Drechslera) tritici-repentis (tan spot) on wheat or P. feres (net blotch) on barley; Pyricularia spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Ramularia spp., e. g. R. collo-cygni (Ram ularia leaf spots,
Physiological leaf spots) on barley and R. beticola on sugar beets; Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stolonifer (black mold, soft rot) on strawberries, carrots, cabbage, vines and tomatoes; Rhynchosporium secalis (scald) on barley, rye and triticale; Sarocladium oryzae and S. attenuatum (sheath rot) on rice;
Sclerotinia spp. (stem rot or white mold) on vegetables and field crops, such as rape, sunflowers (e. g. S. sclerotiorum) and soybeans (e. g. S. rolfsii or S. sclerotiorum); Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici (Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Uncinula (syn. Erysiphe) necator (powdery mildew, anamorph: Oidium tuckeri) on vines; Setospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Helminthosporium turcicum) and turf;
Sphacelotheca spp. (smut) on corn, (e. g. S. miliaria: head smut), sorghum und sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora spp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph: Leptosphaeria [syn. Phaeosphaeria] nodorum) on wheat; Synchytrium endobioticum on potatoes (potato wart disease); Taphrina spp., e. g. T. deformans (leaf curl disease) on peaches and T. pruni (plum pocket) on plums; Thielaviopsis spp. (black root rot) on tobacco, pome fruits, vegetables, soybeans and cotton, e. g. T. basicola (syn. Chalara elegans); Tilletia spp. (common bunt or stinking smut) on cereals, such as e. g. T. tritici (syn. T. caries, wheat bunt) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (grey snow mold) on barley or wheat; Urocystis spp., e. g. U.
occulta (stem smut) on rye; Uromyces spp. (rust) on vegetables, such as beans (e. g. U. appendiculatus, syn. U. phaseoli) and sugar beets (e. g. U. betae); Ustilago spp. (loose smut) on cereals (e. g. U. nuda and U. avaenae), corn (e. g. U. maydis: corn smut) and sugar cane; Venturia spp. (scab) on apples (e. g. V. inaequalis) and pears; and Verticillium spp.
(wilt) on various plants, such as fruits and ornamentals, vines, soft fruits, vegetables and field crops, e. g. V. dahliae on strawberries, rape, potatoes and tomatoes.
In particular, compositions of the present invention are effective against plant pathogens in speciality crops such as vine, fruits, hop, vegetables and tabacco - see above list.
The inventive compositions are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials. The term "protection of materials" is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, colling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria. As to the protection of wood and other materials, the particular attention is paid to the following harmful fungi: Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp.,
Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp.; Basidiomycetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Deuteromycetes such as Aspergillus spp.,
Cladosporium spp., Penicillium spp., Trichoderma spp., Alternaria spp., Paecilomyces spp. and Zygomycetes such as Mucor spp., and in addition in the protection of stored products and harvest the following yeast fungi are worthy of note: Candida spp. and Saccharomyces cerevisae.
The method of treatment according to the invention can also be used in the field of protecting stored products or harvest against attack of fungi and microorganisms. According to the present invention, the term "stored products" is understood to denote natural substances of plant or animal origin and their processed forms, which have been taken from the natural life cycle and for which long-term protection is desired. Stored products of crop plant origin, such as plants or parts thereof, for example stalks, leafs, tubers, seeds, fruits or grains, can be protected in the freshly harvested state or in processed form, such as pre-dried, moistened, comminuted, ground, pressed or roasted, which process is also known as post-harvest treatment. Also falling under the definition of stored products is timber, whether in the form of crude timber, such as construction timber, electricity pylons and barriers, or in the form of finished articles, such as furniture or objects made from wood. Stored products of animal origin are hides, leather, furs, hairs and the like. The combinations according the present invention can prevent disadvantageous effects such as decay, discoloration or mold.
Preferably "stored products" is understood to denote natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pomes, stone fruits, soft fruits and citrus fruits and their processed forms.
Plant propagation materials may be treated with the compositions of the invention prophylactically either at or before planting or transplanting.
The invention also relates to agrochemical compositions comprising an auxiliary and at least one compound I and at least one pesticide II according to the invention.
An agrochemical composition comprises a fungicidally effective amount of a compound I and a pesticide II. The term "effective amount" denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound I used.
The compounds I and pesticides II, their N-oxides and salts can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for composition types are suspensions (e. g. SC, OD, FS), emulsifiable concentrates (e. g. EC), emulsions (e. g. EW, EO, ES, ME), capsules (e. g. CS, ZC), pastes, pastilles, wettable pow- ders or dusts (e. g. WP, SP, WS, DP, DS), pressings (e. g. BR, TB, DT), granules (e. g. WG, SG, GR, FG, GG, MG), insecticidal articles (e. g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e. g. GF). These and further compositions types are defined in the "Catalogue of pesticide formulation types and international coding system", Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.
The compositions are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.
Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.
Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e. g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin,
tetrahydronaphthalene, alkylated naphthalenes; alcohols, e. g. ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; glycols; DMSO; ketones, e. g. cyclohexanone; esters, e. g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e. g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof. Suitable solid carriers or fillers are mineral earths, e. g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e. g. cellulose, starch; fertilizers, e. g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e. g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.
Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1 : Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).
Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignin sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and
tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.
Suitable nonionic surfactants are alkoxylates, N-subsituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-subsititued fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinylpyrrolidone, vinylalcohols, or vinylacetate.
Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines.
Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinyl amines or polyethylene amines.
Suitable adjuvants are compounds, which have a negligible or even no pesticidal activity themselves, and which improve the biological performance of the compound I on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.
Suitable thickeners are polysaccharides (e. g. xanthan gum, carboxymethyl cellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.
Suitable bactericides are bronopol and isothiazolinone derivatives such as alkyliso- thiazolinones and benzisothiazolinones.
Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.
Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.
Suitable colorants (e. g. in red, blue, or green) are pigments of low water solubility and water- soluble dyes. Examples are inorganic colorants (e. g. iron oxide, titan oxide, iron
hexacyanoferrate) and organic colorants (e. g. alizarin-, azo- and phthalocyanine colorants).
Suitable tackifiers or binders are polyvinyl pyrrolidones, polyvinyl acetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.
Examples for composition types and their preparation are (wherein active substances denote at least one compound I and one compound II):
i) Water-soluble concentrates (SL, LS)
10-60 wt% active substances and 5-15 wt% wetting agent (e. g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e. g. alcohols) ad 100 wt%. The active substance dissolves upon dilution with water.
ii) Dispersible concentrates (DC)
5-25 wt% active substances and 1 -10 wt% dispersant (e. g. polyvinyl pyrrolidone) are dissolved in organic solvent (e. g. cyclohexanone) ad 100 wt%. Dilution with water gives a dispersion.
iii) Emulsifiable concentrates (EC) 15-70 wt% active substances and 5-10 wt% emulsifiers (e. g. calcium dodecylben- zenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%. Dilution with water gives an emulsion.
iv) Emulsions (EW, EO, ES)
5-40 wt% active substances and 1 -10 wt% emulsifiers (e. g. calcium dodecylben- zenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt% water-insoluble organic solvent (e. g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt% by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion.
v) Suspensions (SC, OD, FS)
In an agitated ball mill, 20-60 wt% active substances are comminuted with addition of 2-10 wt% dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate), 0.1 -2 wt% thickener (e. g. xanthan gum) and ad water ad 100 wt% to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type composition up to 40 wt% binder (e. g. polyvinyl alcohol) is added.
vi) Water-dispersible granules and water-soluble granules (WG, SG)
50-80 wt% active substances are ground finely with addition of dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt% and prepared as water-dispersible or water-soluble granules by means of technical appliances (e. g.
extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance.
vii) Water-dispersible powders and water-soluble powders (WP, SP, WS)
50-80 wt% active substances are ground in a rotor-stator mill with addition of 1 -5 wt% dispersants (e. g. sodium lignosulfonate), 1 -3 wt% wetting agents (e. g. alcohol ethoxylate) and solid carrier (e. g. silica gel) ad 100 wt%. Dilution with water gives a stable dispersion or solution of the active substance.
viii) Gel (GW, GF)
In an agitated ball mill, 5-25 wt% active substances are comminuted with addition of 3-10 wt% dispersants (e. g. sodium lignosulfonate), 1 -5 wt% thickener (e. g. carboxymethyl cellulose) and water ad 100 wt% to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.
iv) Microemulsion (ME)
5-20 wt% active substances are added to 5-30 wt% organic solvent blend (e. g. fatty acid dimethylamide and cyclohexanone), 10-25 wt% surfactant blend (e. g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100 wt%. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.
iv) Microcapsules (CS)
An oil phase comprising 5-50 wt% active substances, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e. g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e. g. aromatic hydrocarbon), and an isocyanate monomer (e. g.
diphenylmethene-4,4'-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). The addition of a polyamine (e. g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1 -10 wt%. The wt% relate to the total CS composition.
ix) Dustable powders (DP, DS)
1 -10 wt% active substances are ground finely and mixed intimately with solid carrier (e. g. finely divided kaolin) ad 100 wt%.
x) Granules (GR, FG)
0.5-30 wt% active substances are ground finely and associated with solid carrier (e. g.
silicate) ad 100 wt%. Granulation is achieved by extrusion, spray-drying or fluidized bed. xi) Ultra-low volume liquids (UL)
1 -50 wt% active substances are dissolved in organic solvent (e. g. aromatic hydrocarbon) ad 100 wt%.
The compositions types i) to xi) may optionally comprise further auxiliaries, such as 0.1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.
The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of active
substances. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).
For the purposes of treatment of plant propagation materials, particularly seeds, solutions for seed treatment (LS), Suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC), and gels (GF) are usually employed. The compositions in question give, after two-to-tenfold dilution, active substance
concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40%, in the ready-to- use preparations. Application can be carried out before or during sowing. Methods for applying or treating compound I and compound II and compositions thereof, respectively, onto plant propagation material, especially seeds include dressing, coating, pelleting, dusting, and soaking as well as in-furrow application methods. Preferably, compound I and pesticide II or the compositions thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating and dusting.
When employed in plant protection, the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, in particular from 0.1 to 0.75 kg per ha.
In treatment of plant propagation materials such as seeds, e. g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seed) are generally required.
When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.
Various types of oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides (e. g. herbicides, insecticides, fungicides, growth regulators, safeners) may be added to the active substances or the compositions comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.
The user applies the composition according to the invention usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.
In the compositions, the compound ratios are advantageously chosen so as to produce a synergistic effect.
The term "synergistic effect" is understood to refer in particular to that defined by Colby's formula (Colby, S. R., "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds, 15, pp. 20-22, 1967).
The term "synergistic effect" is also understood to refer to that defined by application of the Tammes method, (Tammes, P. M. L, "Isoboles, a graphic representation of synergism in pesticides", Netherl. J. Plant Pathol. 70, 1964).
The active compounds, separately or jointly, are prepared as a stock solution comprising 25 mg of active compound which is made up to 10 ml using a mixture of acetone and/or DMSO and the emulsifier Uniperol® EL (wetting agent having an emulsifying and dispersing action based on ethoxylated alkylphenols) in a ratio by volume of solvent/emulsifier of 99:1. The mixture is then made up to 100 ml with water. This stock solution is diluted with the solvent/emulsifier/water mixture described to give the concentration of active compound stated below.
The visually determined percentages of infected leaf areas are converted into efficacies in % of the untreated control.
The efficacy (E) is calculated as follows using Abbot's formula
E = (1 - α/β) ■ 100 a corresponds to the fungicidal infection of the treated plants in % and
β corresponds to the fungicidal infection of the untreated (control) plants in %
An efficacy of 0 means that the infection level of the treated plants corresponds to that of the untreated control plants; an efficacy of 100 means that the treated plants were not infected. The expected efficacies of active compound combinations were determined using Colby's formula (Colby, S.R. "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds, 1J5, pp. 20-22, 1967) and compared with the observed efficacies.
Colby's formula: E = x + y - x »y/100
E expected efficacy, expressed in % of the untreated control, when using the mixture of the active compounds A and B at the concentrations a and b
x efficacy, expressed in % of the untreated control, when using the active compound A at the concentration a
y efficacy, expressed in % of the untreated control, when using the active compound B at the concentration b.
The fungicidal action of the compositions according to the invention can be shown by the tests described below.
Microtest
The active compounds were formulated separately as a stock solution having a concentration of 10000 ppm in dimethyl sulfoxide. The product sulfoxaflor was used as a commercial finished formulation and diluted with water to the stated concentration of the active compound.
M1 Activity against the late blight pathogen Phytophthora infestans in the microtiter test (Phytin)
The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Phytophtora infestans containing a pea juice-based aqueous nutrient medium or DDC medium was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
M2 Activity against the grey mold Botrytis cinerea in the microtiterplate test (Botrci)
The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Botrci cinerea in an aqueous biomalt or yeast-bactopeptone-sodiumacetate solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
M3 Activity against rice blast Pynculana oryzae in the microtiterplate test (Pyrior)
The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Pyricularia oryzae in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
M4 Activity against leaf blotch on wheat caused by Septoria tritici (Septtr)
The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Septoria tritici in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation. M5 Activity against early blight caused by Alternaria solani (Alteso)
The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Alternaria solani in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
M6 Activity against wheat leaf spots caused by Leptosphaeria nodorum (Leptno)
The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of Leptosphaeria nodorum in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation.
The measured parameters were compared to the growth of the active compound-free control variant (100%) and the fungus-free and active compound-free blank value to determine the relative growth in % of the pathogens in the respective active compounds.
These percentages were converted into efficacies.
An efficacy of 0 means that the growth level of the pathogens corresponds to that of the untreated control; an efficacy of 100 means that the pathogens were not growing.
The expected efficacies of active compound mixtures were determined using Colby's formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and compared with the observed efficacies.
Results:
M1 Phytin
Calculated
Active efficacy
Concentration Observed Synergism compound / Mixture according
(ppm) efficacy (%) active mixture to Colby
(%)
I-3* 0.063 - 12 Calculated
Active efficacy
Concentration Observed Synergism compound / Mixture according
(ppm) efficacy (%) active mixture to Colby
(%)
Methiocarb
(II-4) 63 - 51
I-3* 0.063 1 : 1000 75 57 18
Methiocarb
(II-4) 63
M2 Botrci
Figure imgf000042_0001
M3 Pyrior Calculated
Active efficacy
Concentration Observed Synergism compound / Mixture according
(ppm) efficacy (%) active mixture to Colby
(%)
1-3* 0.25 - 10
Methiocarb
(11-4) 63 - 36
1-3* 0.25 1 : 250 100 43 57
Methiocarb
(11-4) 63
M4 Septtr
Figure imgf000043_0001
M5 Alteso
Calculated
Active efficacy
Concentration Observed Synergism compound / Mixture according
(ppm) efficacy (%) active mixture to Colby
(%)
I-3* 0.001 - 9
Triflumezopyrim
(II-7) 0.25 - 36
I-3* 0.001 1 : 250 33 15 18
Triflumezopyrim 0.25 Calculated
Active efficacy
Concentration Observed Synergism compound / Mixture according
(ppm) efficacy (%) active mixture to Colby
(%)
(11-7)
M6 Leptno
Figure imgf000044_0002
-3: 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol
Figure imgf000044_0001

Claims

Claims
1 . Compositions comprising,
1 ) as component I a compound selected from:
compound 1-1 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,
2,4-triazol-1 -yl)pent-
3-yn-2-ol;
compound I-2 1 -[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -cyclopropyl-2-(1 ,2,4- triazol-1 -yl)ethanol;
compound I-3 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-
1 -yl)propan-2-ol;
compound I-4 1 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl-2-
(1 ,2,4-triazol-1 -yl)ethanol;
compound I-5 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1 -
(1 ,2,4-triazol-1 -yl)butan-2-ol;
compound I-6 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pent-3-ynyl]-
1 ,2,4-triazole;
compound I-7 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-
1 - yl)butan-2-ol;
compound I-8 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-cyclopropyl-2- methoxy-ethyl]-1 ,2,4-triazole;
compound I-9 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy- propyl]-1 ,2,4-triazole;
compound 1-10 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3,3-dimethyl-1 -(1 ,2,4- triazol-1 -yl)butan-2-ol,
compound 1-1 1 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-cyclopropyl-
2- methoxy-ethyl]-1 ,2,4-triazole;
compound 1-12 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-3,3- dimethyl-butyl]-1 ,2,4-triazole;
compound 1-13 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy- butyl]1 ,2,4-triazole;
compound 1-14 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-
1 -yl)pent-3-yn-2-ol;
compound 1-15 1 -[2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-2-methoxy- pent-3-ynyl]-1 ,2,4-triazole;
compound 1-16 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-
1 -yl)but-3-yn-2-ol; compound 1-17 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol;
compound 1-18 2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol;
compound 1-19 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1 -(1 ,2,4-triazol-
1 -yl)butan-2-ol;
compound I-20 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-propyl]-
1 ,2,4-triazole;
compound 1-21 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-butyl]-1 ,2,4- riazole;
compound I-22 1 -[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-methoxy-pentyl]-
1 ,2,4-triazole;
compound I-23 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 ,1 ,1 -trifluoro-3-(1 ,2,4- triazol-1 -yl)propan-2-ol;
compound I-24 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-fluoro-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol hydrochloride;
compound I-25 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent- 4-yn-2-ol;
compound I-26 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-
1 -yl)propan-2-ol;
compound I-27 2-[2-chloro-4-(4-fluorophenoxy)phenyl]-1 -methoxy-3-(1 ,2,4-triazol-
1 -yl)propan-2-ol;
compound I-28 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-
1 - yl)pentan-2-ol;
compound I-29 and2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4- triazol-1 -yl)propan-2-ol;
compound I-30 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)butan-
2- ol; and
compound 1-31 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pentan-2-ol;
and
2) as component II a compound selected from the group of oxathiapiprolin (11-1 );
triadimenol (II-2); sulfoxaflor (II-3); methiocarb (II-4); cypermethrin (II-5); thiodicarb (II-6); triflumezopyrim (Mesoionic) (II-7) and flupyradifurone (II-8).
The compositions of claim 1 , wherein component II is oxathiapiprolin (11-1 ).
The compositions of claim 1 , wherein component II is triadimenol (II-2).
4. The compositions of claim 1 , wherein component II is sulfoxaflor (II-3).
5. The compositions of claim 1 , wherein component II is methiocarb (II-4).
6. The compositions of claim 1 , wherein component II is thiodicarb (II-6).
7. The compositions of claim 1 , wherein component II is triflumezopyrim (II-7).
8. The compositions of claim 1 , wherein component II is flupyradifurone (II-8).
9. The compositions of any one of claims 1 to 8, wherein the compound I and the
component II are present in a synergistically effective amount.
10. The compositions of any one of claims 1 to 9, wherein component I and component II are present in a total weight ratio of from 100:1 to 1 :100.
1 1 . The compositions of any one of claims 1 to 10, wherein component I is selected from the compounds 1-1 , I-3, I-4, I-5, 1-13, 1-17, 1-18 and 1-19.
12. The compositions of any one of claims 1 to 10, wherein component I is selected from the compounds I-3, I-4 and I-5.
13. The compositions of any one of claims 1 to 12, further comprising an agrochemical auxiliary.
14. A use of a composition as defined in any of the claims 1 to 12 for combating
phytopathogenic fungi.
15. A method for combating phytopathogenic fungi, comprising treating the fungi or the
materials, plants, the soil or seeds to be protected against fungal attack with an effective amount of a composition as defined in any of the claims 1 to 12.
16. Plant propagation material, coated with the components I and II of the compositions as defined in any one of claims 1 to 12, in an amount of from 0.1 to 10 kg active substances per 100 kg of seed.
PCT/EP2015/063269 2014-06-25 2015-06-15 Pesticidal compositions WO2015197393A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US15/319,963 US10212934B2 (en) 2014-06-25 2015-06-15 Pesticidal compositions
UAA201700550A UA119672C2 (en) 2014-06-25 2015-06-15 Pesticidal compositions
CA2951177A CA2951177C (en) 2014-06-25 2015-06-15 Pesticidal compositions
EP17178393.9A EP3269245B1 (en) 2014-06-25 2015-06-15 Pesticidal compositions
EA201790064A EA032078B1 (en) 2014-06-25 2015-06-15 Pesticidal compositions
BR112016030116-1A BR112016030116B1 (en) 2014-06-25 2015-06-15 compositions, use of a composition, method for combating fungi and plant propagation material
EP15728026.4A EP3160229A1 (en) 2014-06-25 2015-06-15 Pesticidal compositions
AU2015281187A AU2015281187B2 (en) 2014-06-25 2015-06-15 Pesticidal compositions
CN201580033485.7A CN106793776A (en) 2014-06-25 2015-06-15 Composition pesticide
US16/245,469 US20190142007A1 (en) 2014-06-25 2019-01-11 Pesticidal Compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14173980.5 2014-06-25
EP14173980 2014-06-25

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US15/319,963 A-371-Of-International US10212934B2 (en) 2014-06-25 2015-06-15 Pesticidal compositions
US16/245,469 Continuation US20190142007A1 (en) 2014-06-25 2019-01-11 Pesticidal Compositions

Publications (1)

Publication Number Publication Date
WO2015197393A1 true WO2015197393A1 (en) 2015-12-30

Family

ID=50980249

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/063269 WO2015197393A1 (en) 2014-06-25 2015-06-15 Pesticidal compositions

Country Status (9)

Country Link
US (2) US10212934B2 (en)
EP (3) EP3160229A1 (en)
CN (1) CN106793776A (en)
AU (1) AU2015281187B2 (en)
BR (1) BR112016030116B1 (en)
CA (1) CA2951177C (en)
EA (3) EA201892682A1 (en)
UA (1) UA119672C2 (en)
WO (1) WO2015197393A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016079043A1 (en) * 2014-11-18 2016-05-26 BASF Agro B.V. Pesticidal compositions comprising a triazole compound
WO2017072166A1 (en) 2015-10-27 2017-05-04 Bayer Cropscience Aktiengesellschaft Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
WO2017207368A1 (en) * 2016-06-02 2017-12-07 BASF Agro B.V. Fungicidal compositions
US10206403B2 (en) 2014-07-14 2019-02-19 Basf Se Pesticidal compositions
US10238106B2 (en) 2014-03-12 2019-03-26 Basf Se Carbonates of alcohol alkoxylates as adjuvants for crop protection
US10512267B2 (en) 2013-07-08 2019-12-24 BASF Agro, B.V. Compositions comprising a triazole compound and a biopesticide
US10519122B2 (en) 2013-01-09 2019-12-31 BASF Agro B.V. Process for the preparation of substituted oxiranes and triazoles
US10701937B2 (en) 2015-02-11 2020-07-07 Basf Se Pesticidal mixture comprising a pyrazole compound, an insecticide and a fungicide
US10759767B2 (en) 2012-12-20 2020-09-01 BASF Agro B.V. Compositions comprising a triazole compound
US10779536B2 (en) 2014-11-07 2020-09-22 Basf Se Pesticidal mixtures
US10905122B2 (en) 2016-03-16 2021-02-02 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on cereals
US11051510B2 (en) 2014-01-30 2021-07-06 Basf Se Asymmetric formales and acetales as adjuvants for crop protection
US11185078B2 (en) 2016-02-09 2021-11-30 Basf Se Mixtures and compositions comprising Paenibacillus strains or metabolites thereof and other biopesticides
US11241012B2 (en) 2016-03-16 2022-02-08 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean
US11425909B2 (en) 2016-03-16 2022-08-30 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on fruits

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111202079A (en) * 2020-03-06 2020-05-29 江苏丘陵地区镇江农业科学研究所 Pesticide composition containing trifluoro-benzene pyrimidine, preparation method and application

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126430A2 (en) * 1983-05-19 1984-11-28 Ciba-Geigy Ag Process for the preparation of 1-triazolylethylether-derivatives, and microbicidal compositions containing novel 1-triazolyl-phenoxyphenylethylether-derivatives as active ingredients and their use
EP0354183A2 (en) * 1988-08-04 1990-02-07 Ciba-Geigy Ag Microbicidal agents
US4940720A (en) * 1989-08-02 1990-07-10 Ciba-Geigy Corporation Microbicidal compositions
US20100240619A1 (en) * 2007-10-23 2010-09-23 Vann Gregory Fungicidal mixtures
WO2013007767A1 (en) * 2011-07-13 2013-01-17 Basf Se Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
WO2013024080A1 (en) * 2011-08-15 2013-02-21 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl ]-2-alkoxy-2-cyclyl-ethyl}-1h [1,2,4]triazole compounds
WO2013024083A1 (en) * 2011-08-15 2013-02-21 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-alkoxy-2-alkynyl/alkenyl-ethyl}-1h-[1,2,4]triazole compounds
US20140127322A1 (en) * 2009-04-22 2014-05-08 E I Du Pont De Nemours And Company Solid forms of an azocyclic amide

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2325878A1 (en) 1973-05-22 1974-12-12 Kalk Chemische Fabrik Gmbh Trifluoromethyl-phenyl aryl ethers - useful as heat-transfer fluids, lubricant fluids, dielectrics, and intermediates for pharmaceuticals
GB1543964A (en) 1976-04-08 1979-04-11 Ici Ltd Method of antagonising herbicides on soyabean and cotton
DE2725314A1 (en) 1977-06-04 1978-12-14 Bayer Ag 1- (2-PHENYLAETHYL) TRIAZOLIUM SALTS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS FUNGICIDES
CH647513A5 (en) 1979-11-13 1985-01-31 Sandoz Ag TRIAZOLE DERIVATIVES, THEIR PRODUCTION AND USE.
JPS5764632A (en) 1980-10-09 1982-04-19 Mitsui Toatsu Chem Inc Novel 2-arylethyl ether derivative and thioether derivative, their production and insecticide and acaricide
DE3140276A1 (en) 1981-10-10 1983-04-28 Bayer Ag, 5090 Leverkusen PHENOXYPHENYL-AZOLYLMETHYL-KETONE AND CARBINOLS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS FUNGICIDES AND AS INTERMEDIATE PRODUCTS
PH19709A (en) 1982-11-23 1986-06-16 Ciba Geigy Ag Microbicidal 1-carbonyl-1-phenoxyphenyl-2-azolylethanol derivatives
BG48681A3 (en) 1982-12-14 1991-04-15 Ciba Geigy Ag Fungicide means
US5304732A (en) 1984-03-06 1994-04-19 Mgi Pharma, Inc. Herbicide resistance in plants
BR8600161A (en) 1985-01-18 1986-09-23 Plant Genetic Systems Nv CHEMICAL GENE, HYBRID, INTERMEDIATE PLASMIDIO VECTORS, PROCESS TO CONTROL INSECTS IN AGRICULTURE OR HORTICULTURE, INSECTICIDE COMPOSITION, PROCESS TO TRANSFORM PLANT CELLS TO EXPRESS A PLANTINIDE TOXIN, PRODUCED BY CULTURES, UNITED BY BACILLA
EP0242236B2 (en) 1986-03-11 1996-08-21 Plant Genetic Systems N.V. Plant cells resistant to glutamine synthetase inhibitors, made by genetic engineering
DE3801233A1 (en) 1987-01-21 1988-08-04 Ciba Geigy Ag Microbicide
ES2016660B3 (en) 1987-01-21 1990-11-16 Ciba-Geigy Ag MICROBICIDE AGENT.
DE3733755A1 (en) 1987-10-06 1989-04-20 Bayer Ag Process for the preparation of 2-(4-chlorophenylethyl)-2-tert-butyloxirane
FR2629098B1 (en) 1988-03-23 1990-08-10 Rhone Poulenc Agrochimie CHEMICAL GENE OF HERBICIDE RESISTANCE
ES2054087T3 (en) 1988-08-04 1994-08-01 Ciba Geigy Ag MICROBICIDE PRODUCTS.
NZ231804A (en) 1988-12-19 1993-03-26 Ciba Geigy Ag Insecticidal toxin from leiurus quinquestriatus hebraeus
ATE241699T1 (en) 1989-03-24 2003-06-15 Syngenta Participations Ag DISEASE RESISTANT TRANSGENIC PLANT
ES2074547T3 (en) 1989-11-07 1995-09-16 Pioneer Hi Bred Int LARVICID LECTINES, AND INDUCED RESISTANCE OF PLANTS TO INSECTS.
DE4003180A1 (en) 1990-02-03 1991-08-08 Bayer Ag Halo-allyl-azolyl derivs. - are microbicide(s) for protecting plants and materials from fungal and bacterial attack
EP0536330B1 (en) 1990-06-25 2002-02-27 Monsanto Technology LLC Glyphosate tolerant plants
DE4025204A1 (en) 1990-08-09 1992-02-13 Bayer Ag HALOGENALKYL-AZOLYL DERIVATIVES
EP0470466A3 (en) 1990-08-09 1992-07-29 Bayer Ag Halogenalkyl-azolyl derivatives
UA48104C2 (en) 1991-10-04 2002-08-15 Новартіс Аг Dna fragment including sequence that codes an insecticide protein with optimization for corn, dna fragment providing directed preferable for the stem core expression of the structural gene of the plant related to it, dna fragment providing specific for the pollen expression of related to it structural gene in the plant, recombinant dna molecule, method for obtaining a coding sequence of the insecticide protein optimized for corn, method of corn plants protection at least against one pest insect
US5530195A (en) 1994-06-10 1996-06-25 Ciba-Geigy Corporation Bacillus thuringiensis gene encoding a toxin active against insects
DE19521487A1 (en) 1995-06-13 1996-12-19 Bayer Ag Mercapto-triazolyl-dioxacycloalkanes
US5773704A (en) 1996-04-29 1998-06-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Herbicide resistant rice
US5773702A (en) 1996-07-17 1998-06-30 Board Of Trustees Operating Michigan State University Imidazolinone herbicide resistant sugar beet plants
SK286030B6 (en) 1996-07-17 2008-01-07 Michigan State University Imidazolinone herbicide resistant sugar beet plants
US6348643B1 (en) 1998-10-29 2002-02-19 American Cyanamid Company DNA sequences encoding the arabidopsis acetohydroxy-acid synthase small subunit and methods of use
AU5920601A (en) 2000-04-28 2001-11-12 American Cyanamid Co Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots, maize, rice and wheat plants resistant to the imidazolinone herbicides
ES2243543T3 (en) 2000-08-25 2005-12-01 Syngenta Participations Ag HYBRIDS OF BACILLUS THURIGIENSIS CRYSTAL PROTEINS.
AR035858A1 (en) 2001-04-23 2004-07-21 Bayer Corp CHROME DERIVATIVES 2,6-SUBSTITUTES, PHARMACEUTICAL COMPOSITIONS, USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF USEFUL MEDICINES AS BETA-3 ADRENORRECEPTING AGONISTS
MXPA04001056A (en) 2001-08-09 2005-02-17 Northwest Plant Breeding Compa Wheat plants having increased resistance to imidazolinone herbicides.
US7521599B2 (en) 2001-08-09 2009-04-21 University Of Saskatchewan Wheat plants having increased resistance to imidazolinone herbicides
BRPI0211809B1 (en) 2001-08-09 2019-04-24 University Of Saskatchewan METHOD FOR THE CONTROL OF WEED HERBS IN THE NEIGHBORHOODS OF A WHEAT OR TRITICALE PLANT, METHOD FOR MODIFYING THE TOLERANCE OF A WHEAT OR TRITICALE PLANT AND AN IMMEDAZOLINET PRODUCT RESULTING PLANT A HERBICIDE OF IMIDAZOLINONE
US7230167B2 (en) 2001-08-31 2007-06-12 Syngenta Participations Ag Modified Cry3A toxins and nucleic acid sequences coding therefor
JP4152884B2 (en) 2001-09-27 2008-09-17 杏林製薬株式会社 Diaryl ether derivatives and their addition salts and immunosuppressants
AU2002361696A1 (en) 2001-12-17 2003-06-30 Syngenta Participations Ag Novel corn event
US20030166476A1 (en) 2002-01-31 2003-09-04 Winemiller Mark D. Lubricating oil compositions with improved friction properties
CA2492167C (en) 2002-07-10 2015-06-16 The Department Of Agriculture, Western Australia Wheat plants having increased resistance to imidazolinone herbicides
US9382526B2 (en) 2003-05-28 2016-07-05 Basf Aktiengesellschaft Wheat plants having increased tolerance to imidazolinone herbicides
ES2379553T3 (en) 2003-08-29 2012-04-27 Instituto Nacional De Tecnologia Agropecuaria Rice plants that have increased tolerance to imidazolinone herbicides
EP1761498A1 (en) 2004-06-18 2007-03-14 Basf Aktiengesellschaft 1-methyl-3-difluoromethyl-pyrazol-4-carbonic acid-(ortho-phenyl)-anilides, and use thereof as a fungicide
WO2005123689A1 (en) 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-trifluoromethyl-pyrazole-4-carboxylic acid (ortho-phenyl)-anilides and to use thereof as fungicide
GB0418048D0 (en) 2004-08-12 2004-09-15 Syngenta Participations Ag Method for protecting useful plants or plant propagation material
CA2598582A1 (en) 2005-02-17 2006-08-24 Georg Hess Use of nt-proanp/nt-probnp ratio for diagnosing cardiac dysfunctions
JP5055263B2 (en) 2005-03-30 2012-10-24 ダエウン ファーマシューティカル カンパニー リミテッド Antifungal triazole derivatives
MX2007013893A (en) 2005-05-07 2008-01-28 Bayer Cropscience Sa Pesticidal substituted phenylethers.
SI1763998T1 (en) 2005-09-16 2007-10-31 Syngenta Participations Ag Fungicidal compositions
US8492312B2 (en) 2005-11-10 2013-07-23 Regents Of The University Of Minnestoa Systemic plant conditioning composition
DE102006015467A1 (en) 2006-03-31 2007-10-04 Bayer Cropscience Ag New cyclic enamine ketone derivatives useful for controlling pests, especially insects
KR20080062876A (en) 2006-12-29 2008-07-03 주식회사 대웅제약 Novel antifungal triazole derivatives
CN101225074A (en) 2007-01-18 2008-07-23 青岛科技大学 Synthesis of compound containing aryl ether triazole
JP2011520970A (en) 2008-05-19 2011-07-21 オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド Substituted imidazopyrazines and imidazotriazines
KR101647703B1 (en) * 2009-03-25 2016-08-11 바이엘 인텔렉쳐 프로퍼티 게엠베하 Synergistic combinations of active ingredients
MA33361B1 (en) 2009-06-18 2012-06-01 Basf Se Triazol compounds carrying a sulfur substitute
CN102762542B (en) 2010-02-12 2015-07-22 大熊制药株式会社 Novel antifungal triazole derivatives
JP6042335B2 (en) 2010-09-15 2016-12-14 ノヴォ ノルディスク アー／エス Factor VIII mutant with reduced cellular uptake
EP2619203A4 (en) 2010-09-20 2014-04-16 Glaxo Group Ltd Tricyclic compounds, preparation methods, and their uses
MX2013006939A (en) * 2010-12-27 2013-07-22 Sumitomo Chemical Co Arthropod pest control composition and method for controlling arthropod pests.
TWI528899B (en) * 2010-12-29 2016-04-11 杜邦股份有限公司 Mesoionic pesticides
US9137996B2 (en) 2011-07-15 2015-09-22 Basf Se Fungicidal alkyl- and aryl-substituted 2[-2-chloro-4-(dihalo-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
US9173402B2 (en) 2011-07-15 2015-11-03 Basf Se Fungicidal alkyl-substituted 2[2-chloro-4-(4-chioro-phenoxy)-phenyl]-1[1,2,4]triazol-1-yl-ethanol compounds
CN103814017A (en) 2011-07-15 2014-05-21 巴斯夫欧洲公司 Fungicidal phenylalkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
EP2559688A1 (en) 2011-08-15 2013-02-20 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-butoxy-ethyl}-1h [1,2,4]triazole compounds
WO2013024082A1 (en) 2011-08-15 2013-02-21 Basf Se Fungicidal substituted 1-{2-cyclyloxy-2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-ethyl}-1h-[1,2,4]triazole compounds
CN103827096A (en) 2011-08-15 2014-05-28 巴斯夫欧洲公司 Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-alkoxy-hexyl}-1h [1,2,4]triazole compounds
US20140162876A1 (en) 2011-08-15 2014-06-12 Basf Se Fungicidal substituted 1--1H-[1,2,4]triazole compounds
EP2744792B1 (en) 2011-08-15 2016-10-12 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-alkynyloxy-ethyl}-1h-[1,2,4]triazole compounds
UY34259A (en) 2011-08-15 2013-02-28 Basf Se FUNGICIDE COMPOUNDS OF 1- {2- [2-HALO-4- (4-HALOGEN-Phenoxy) -Phenyl] -2-ALCOXI-3-METHYL-BUTIL} -1H- [1,2,4] SUBSTITUTED TRIAZOL
US9483544B2 (en) 2012-05-25 2016-11-01 Crimson Hexagon, Inc. Systems and methods for calculating category proportions
AR093828A1 (en) 2012-10-01 2015-06-24 Basf Se ACTIVE MIXTURES AS PESTICIDES, WHICH INCLUDE ANTRANILAMIDE COMPOUNDS
WO2014079771A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
US10537110B2 (en) 2012-11-22 2020-01-21 Basf Corporation Pesticidal mixtures
WO2014079772A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079841A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079770A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
EP2941125A1 (en) 2012-11-22 2015-11-11 BASF Corporation Pesticidal mixtures
WO2014079766A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
BR112015011777B1 (en) 2012-11-22 2019-09-24 Basf Corporation SYNERGIC MIXTURE, KIT FOR PREPARING USEFUL PESTICIDE COMPOSITION, PESTICIDE COMPOSITION AND METHOD FOR PROTECTING PLANT PROPAGATION MATERIAL
WO2014079774A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079728A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079804A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079814A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079724A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079752A1 (en) 2012-11-23 2014-05-30 Basf Se Pesticidal mixtures
WO2014079730A1 (en) 2012-11-23 2014-05-30 Basf Se Pesticidal mixtures
WO2014079769A1 (en) 2012-11-23 2014-05-30 Basf Se Pesticidal mixtures
WO2014079754A1 (en) 2012-11-23 2014-05-30 Basf Se Pesticidal mixtures
WO2014079813A1 (en) 2012-11-23 2014-05-30 Basf Se Pesticidal mixtures
EA030875B1 (en) 2012-12-20 2018-10-31 Басф Агро Б.В. Compositions comprising a triazole compound
CN104936450A (en) 2012-12-20 2015-09-23 巴斯夫欧洲公司 Compositions comprising triazole compound
CA2916777A1 (en) 2013-07-08 2015-01-15 BASF Agro B.V. Compositions comprising a triazole compound and a biopesticide
EP2835052A1 (en) * 2013-08-07 2015-02-11 Basf Se Fungicidal mixtures comprising pyrimidine fungicides
EP3099168B1 (en) 2014-01-30 2019-09-11 Basf Se Asymmetric formales and acetales as adjuvants for crop protection
EA032334B1 (en) 2014-03-12 2019-05-31 Басф Се Fungicidal formulation comprising alkoxylate, method of preparing same, seed comprising same, method of controlling phytopathogenic fungi, use of alkoxylate for improving efficacy of fungicide, and alkoxylate
AU2015257857B2 (en) 2014-05-06 2019-01-17 Basf Se Composition comprising a pesticide and a hydroxyalkyl polyoxylene glycol ether

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126430A2 (en) * 1983-05-19 1984-11-28 Ciba-Geigy Ag Process for the preparation of 1-triazolylethylether-derivatives, and microbicidal compositions containing novel 1-triazolyl-phenoxyphenylethylether-derivatives as active ingredients and their use
EP0354183A2 (en) * 1988-08-04 1990-02-07 Ciba-Geigy Ag Microbicidal agents
US4940720A (en) * 1989-08-02 1990-07-10 Ciba-Geigy Corporation Microbicidal compositions
US20100240619A1 (en) * 2007-10-23 2010-09-23 Vann Gregory Fungicidal mixtures
US20140127322A1 (en) * 2009-04-22 2014-05-08 E I Du Pont De Nemours And Company Solid forms of an azocyclic amide
WO2013007767A1 (en) * 2011-07-13 2013-01-17 Basf Se Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
WO2013024080A1 (en) * 2011-08-15 2013-02-21 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl ]-2-alkoxy-2-cyclyl-ethyl}-1h [1,2,4]triazole compounds
WO2013024083A1 (en) * 2011-08-15 2013-02-21 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-alkoxy-2-alkynyl/alkenyl-ethyl}-1h-[1,2,4]triazole compounds

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10759767B2 (en) 2012-12-20 2020-09-01 BASF Agro B.V. Compositions comprising a triazole compound
US10981883B2 (en) 2013-01-09 2021-04-20 BASF Agro B.V. Process for the preparation of substituted oxiranes and triazoles
US10519122B2 (en) 2013-01-09 2019-12-31 BASF Agro B.V. Process for the preparation of substituted oxiranes and triazoles
US10512267B2 (en) 2013-07-08 2019-12-24 BASF Agro, B.V. Compositions comprising a triazole compound and a biopesticide
US11051510B2 (en) 2014-01-30 2021-07-06 Basf Se Asymmetric formales and acetales as adjuvants for crop protection
US10827748B2 (en) 2014-03-12 2020-11-10 Basf Se Carbonates of alcohol alkoxylates as adjuvants for crop protection
US10238106B2 (en) 2014-03-12 2019-03-26 Basf Se Carbonates of alcohol alkoxylates as adjuvants for crop protection
US10206403B2 (en) 2014-07-14 2019-02-19 Basf Se Pesticidal compositions
US10779536B2 (en) 2014-11-07 2020-09-22 Basf Se Pesticidal mixtures
WO2016079043A1 (en) * 2014-11-18 2016-05-26 BASF Agro B.V. Pesticidal compositions comprising a triazole compound
US10701937B2 (en) 2015-02-11 2020-07-07 Basf Se Pesticidal mixture comprising a pyrazole compound, an insecticide and a fungicide
WO2017072166A1 (en) 2015-10-27 2017-05-04 Bayer Cropscience Aktiengesellschaft Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
US11185078B2 (en) 2016-02-09 2021-11-30 Basf Se Mixtures and compositions comprising Paenibacillus strains or metabolites thereof and other biopesticides
US10905122B2 (en) 2016-03-16 2021-02-02 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on cereals
US11241012B2 (en) 2016-03-16 2022-02-08 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean
US11425909B2 (en) 2016-03-16 2022-08-30 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on fruits
WO2017207368A1 (en) * 2016-06-02 2017-12-07 BASF Agro B.V. Fungicidal compositions

Also Published As

Publication number Publication date
EA032078B1 (en) 2019-04-30
CA2951177C (en) 2023-07-04
EP3269245A1 (en) 2018-01-17
EP3269245B1 (en) 2023-08-16
BR112016030116B1 (en) 2021-07-06
US20170127676A1 (en) 2017-05-11
EA201892682A1 (en) 2019-04-30
EA201892678A1 (en) 2019-04-30
EA201790064A1 (en) 2017-07-31
AU2015281187B2 (en) 2018-10-04
US10212934B2 (en) 2019-02-26
UA119672C2 (en) 2019-07-25
AU2015281187A1 (en) 2017-01-12
CN106793776A (en) 2017-05-31
EP3160229A1 (en) 2017-05-03
CA2951177A1 (en) 2015-12-30
EP3272217A1 (en) 2018-01-24
EA036537B1 (en) 2020-11-20
US20190142007A1 (en) 2019-05-16
BR112016030116A2 (en) 2017-08-22

Similar Documents

Publication Publication Date Title
AU2015281187B2 (en) Pesticidal compositions
US10206403B2 (en) Pesticidal compositions
US11477984B2 (en) Fungicidal mixtures of mefentrifluconazole
WO2016174042A1 (en) Pesticidal compositions
EP3419423A1 (en) Fungicidal mixtures comprising fluxapyroxad
WO2016078995A1 (en) Pesticidal compositions
US20190246640A1 (en) Fungicidal mixtures comprising a carboxamide
EP3915379A1 (en) Pesticidal mixtures
WO2017207368A1 (en) Fungicidal compositions
EP3412150A1 (en) Mixtures of meptyldinocap with sdhi fungicides
WO2019166252A1 (en) Fungicidal mixtures comprising fenpropidin
US20190208783A1 (en) Fungicidal Mixtures Comprising a Formamidine
EP3643175A1 (en) Ternary pesticidal mixtures containing metyltetraprole and fenpropimorph
EP3533333A1 (en) Fungicidal mixtures comprising pydiflumetofen
EP3245872A1 (en) Pesticidal compositions
EP3817553B1 (en) Pesticidal mixtures
EP3536150A1 (en) Fungicidal mixtures comprising fluxapyroxad
EP3530116A1 (en) Fungicidal mixtures comprising xemium
EP3530118A1 (en) Fungicidal mixtures
EP3533331A1 (en) Fungicidal mixtures comprising pydiflumetofen
EP3427587A1 (en) Pesticidal mixtures
WO2019020540A1 (en) Pesticidal mixtures
EP3539384A1 (en) 3-components mixtures comprising fluxapyroxad

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15728026

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2951177

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2015728026

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015728026

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 15319963

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112016030116

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2015281187

Country of ref document: AU

Date of ref document: 20150615

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: A201700550

Country of ref document: UA

WWE Wipo information: entry into national phase

Ref document number: 201790064

Country of ref document: EA

ENP Entry into the national phase

Ref document number: 112016030116

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20161221